<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">58825</article-id><article-id pub-id-type="doi">10.7554/eLife.58825</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group></article-categories><title-group><article-title>Cell-cycle-gated feedback control mediates desensitization to interferon stimulation</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-188692"><name><surname>Mudla</surname><given-names>Anusorn</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1132-2307</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-130829"><name><surname>Jiang</surname><given-names>Yanfei</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4479-1874</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188702"><name><surname>Arimoto</surname><given-names>Kei-ichiro</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188703"><name><surname>Xu</surname><given-names>Bingxian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188704"><name><surname>Rajesh</surname><given-names>Adarsh</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188705"><name><surname>Ryan</surname><given-names>Andy P</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-7218"><name><surname>Wang</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-49517"><name><surname>Daugherty</surname><given-names>Matthew D</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4879-9603</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188706"><name><surname>Zhang</surname><given-names>Dong-Er</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-55534"><name><surname>Hao</surname><given-names>Nan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2857-4789</contrib-id><email>nhao@ucsd.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Section of Molecular Biology, Division of Biological Sciences, University of California, San Diego</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Department of Bioengineering, University of California, San Diego</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Department of Chemistry and Biochemistry, University of California, San Diego</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Department of Pathology, Moores UCSD Cancer Center, University of California, San Diego</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Graw</surname><given-names>Frederik</given-names></name><role>Reviewing Editor</role><aff><institution>Heidelberg University</institution><country>Germany</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Walczak</surname><given-names>Aleksandra M</given-names></name><role>Senior Editor</role><aff><institution>École Normale Supérieure</institution><country>France</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>18</day><month>09</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e58825</elocation-id><history><date date-type="received" iso-8601-date="2020-05-12"><day>12</day><month>05</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-09-02"><day>02</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Mudla et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Mudla et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-58825-v1.pdf"/><abstract><p>Cells use molecular circuits to interpret and respond to extracellular cues, such as hormones and cytokines, which are often released in a temporally varying fashion. In this study, we combine microfluidics, time-lapse microscopy, and computational modeling to investigate how the type I interferon (IFN)-responsive regulatory network operates in single human cells to process repetitive IFN stimulation. We found that IFN-α pretreatments lead to opposite effects, priming versus desensitization, depending on input durations. These effects are governed by a regulatory network composed of a fast-acting positive feedback loop and a delayed negative feedback loop, mediated by upregulation of ubiquitin-specific peptidase 18 (USP18). We further revealed that USP18 upregulation can only be initiated at the G1/early S phases of cell cycle upon the treatment onset, resulting in heterogeneous and delayed induction kinetics in single cells. This cell cycle gating provides a temporal compartmentalization of feedback loops, enabling duration-dependent desensitization to repetitive stimulations.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>interferons</kwd><kwd>desensitization</kwd><kwd>signal dynamics</kwd><kwd>single-cell analysis</kwd><kwd>time-lapse microscopy</kwd><kwd>computational modeling</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>GM111458</award-id><principal-award-recipient><name><surname>Hao</surname><given-names>Nan</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>CA177305</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Dong-Er</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>CA232147</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Dong-Er</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>GM133633</award-id><principal-award-recipient><name><surname>Daugherty</surname><given-names>Matthew D</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000875</institution-id><institution>Pew Charitable Trusts</institution></institution-wrap></funding-source><award-id>Pew Biomedical Research Scholars</award-id><principal-award-recipient><name><surname>Daugherty</surname><given-names>Matthew D</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution>Government of Thailand</institution></institution-wrap></funding-source><award-id>DPST training scholarship</award-id><principal-award-recipient><name><surname>Mudla</surname><given-names>Anusorn</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>GM007240 Training Grant</award-id><principal-award-recipient><name><surname>Ryan</surname><given-names>Andy P</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Cell cycle gating enables a temporal compartmentalization of negative vs positive feedback control processes, leading to differential responses to repetitive interferon stimulations.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Under physiological conditions, cells often encounter environmental cues that change over time. Many hormones, cytokines, and signal factors are released in a temporally varying fashion. Increasing evidence demonstrated that cells can use complex signaling networks to interpret the dynamic patterns of these inputs and initiate appropriate cellular responses (<xref ref-type="bibr" rid="bib75">Purvis and Lahav, 2013</xref>; <xref ref-type="bibr" rid="bib8">Behar and Hoffmann, 2010</xref>). For example, the mitogen-activated protein kinase Hog1 pathway in the yeast <italic>Saccharomyces cerevisiae</italic> responds to the various frequencies of oscillating osmotic stress and differentially control the growth rate under stress (<xref ref-type="bibr" rid="bib63">Mitchell et al., 2015</xref>; <xref ref-type="bibr" rid="bib30">Hersen et al., 2008</xref>; <xref ref-type="bibr" rid="bib60">Mettetal et al., 2008</xref>). Moreover, the gene regulatory program mediated by the yeast general stress-responsive transcription factors (TFs) Msn2 and Msn4 can decode various input pulses and induce differential gene expression (<xref ref-type="bibr" rid="bib28">Hao and O'Shea, 2012</xref>; <xref ref-type="bibr" rid="bib27">Hao et al., 2013</xref>; <xref ref-type="bibr" rid="bib25">Hansen and O'Shea, 2013</xref>; <xref ref-type="bibr" rid="bib2">AkhavanAghdam et al., 2016</xref>). In mammalian systems, it has been shown that the nuclear factor κB (NFκB) pathway can process the pulsatile stimulation of tumor necrosis factor-α (TNF-α) to determine the timing and specificity of downstream gene expression (<xref ref-type="bibr" rid="bib4">Ashall et al., 2009</xref>; <xref ref-type="bibr" rid="bib96">Tay et al., 2010</xref>; <xref ref-type="bibr" rid="bib66">Nelson et al., 2004</xref>). Similarly, the p53 tumor suppressor differentially regulates target genes and cell fates by processing temporal patterns of DNA damage cues (<xref ref-type="bibr" rid="bib29">Harton et al., 2019</xref>; <xref ref-type="bibr" rid="bib74">Purvis et al., 2012</xref>; <xref ref-type="bibr" rid="bib7">Batchelor et al., 2011</xref>). Intriguingly, many of these studies observed that individual cells exhibit widely different behaviors even to the same stimuli, and, as a result, population-based measurements may obscure the actual response dynamics of individual cells, leading to inaccurate interpretation of the data. Furthermore, these observed cell-to-cell variabilities play important roles in enhancing the diversity of physiological behaviors and biological functions (<xref ref-type="bibr" rid="bib32">Hsu et al., 2019</xref>; <xref ref-type="bibr" rid="bib78">Reyes et al., 2018</xref>; <xref ref-type="bibr" rid="bib102">Yang et al., 2017</xref>; <xref ref-type="bibr" rid="bib69">Paek et al., 2016</xref>; <xref ref-type="bibr" rid="bib62">Min et al., 2020</xref>). In this study, we focus on interferon (IFN)-α signaling in HeLa cells and investigate how the IFN-driven gene regulatory network operates in single human cells to decode various signal dynamics.</p><p>IFN-α is a member of the type I IFN family of cytokines, which are synthesized and secreted in mammals upon pathogen infection and initiate innate immune responses to limit pathogen spread via reducing protein production, upregulating antiproliferative and antiviral genes, and programmed cell death (<xref ref-type="bibr" rid="bib84">Schneider et al., 2014</xref>; <xref ref-type="bibr" rid="bib6">Barber and defense, 2001</xref>). IFN-α has also been clinically used in treatments of a variety of diseases, such as hepatitis B and C infection, HIV infection, melanoma, kidney cancer, leukemia and lymphoma (<xref ref-type="bibr" rid="bib100">Watanabe et al., 2013</xref>; <xref ref-type="bibr" rid="bib59">Medrano et al., 2017</xref>). IFN-α exerts its anti-pathogenic and anti-proliferative effects by activating the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway, leading to the expression of over 300 IFN-stimulated genes (ISGs) (<xref ref-type="bibr" rid="bib84">Schneider et al., 2014</xref>; <xref ref-type="bibr" rid="bib85">Schoggins and Rice, 2011</xref>). IFN-α binds to a heterodimeric transmembrane receptor, the IFN-α receptor (IFNAR), triggering the activation of receptor-associated kinases Janus kinase 1 (JAK1) and tyrosine kinase 2 (TYK2), which in turn phosphorylate transcription factors signal transducer and activator of transcription 1 (STAT1) and STAT2. The phosphorylated STAT1 and STAT2 dimerize and associate with IFN-regulatory factor 9 (IRF9) to form IFN-stimulated gene factor 3 (ISGF3) complex. ISGF3 then translocates to the nucleus and binds to the DNA consensus sequences, known as IFN-stimulated response element (ISRE), activating the transcription of ISGs (<xref ref-type="bibr" rid="bib73">Platanias, 2005</xref>; <xref ref-type="bibr" rid="bib86">Schreiber, 2017</xref>). The duration and strength of the IFN-mediated inflammatory responses are tightly controlled in mammals. A response that is too short or too weak will fail to limit pathogen spread, whereas a response that is too prolonged or too strong will result in tissue damage, organ failure, and carcinogenesis (<xref ref-type="bibr" rid="bib15">Choubey and Moudgil, 2011</xref>; <xref ref-type="bibr" rid="bib18">Crow, 2016</xref>; <xref ref-type="bibr" rid="bib58">McNab et al., 2015</xref>). In many epidemics, uncontrolled inflammatory responses to infection have led to the cytokine storm and high mortality (<xref ref-type="bibr" rid="bib12">Cameron et al., 2008</xref>; <xref ref-type="bibr" rid="bib13">Carrero, 2013</xref>).</p><p>Although the molecular components of the JAK-STAT pathway have been well characterized, how they are regulated to generate appropriate responses to dynamic IFN-α inputs remains largely elusive. In particular, during chronic inflammation, cells receive varying IFN signals from neighboring cells (<xref ref-type="bibr" rid="bib9">Beltra and Decaluwe, 2016</xref>; <xref ref-type="bibr" rid="bib45">Landskron et al., 2014</xref>; <xref ref-type="bibr" rid="bib71">Perry et al., 2005</xref>). However, previous studies have reported opposing results regarding the effect of IFN-α pretreatment. In some studies, a prior exposure to IFN-α accelerates cells’ responses to the second IFN input, enabling a ‘priming’ effect (<xref ref-type="bibr" rid="bib1">Abreu et al., 1979</xref>; <xref ref-type="bibr" rid="bib44">Kuri et al., 2009</xref>; <xref ref-type="bibr" rid="bib80">Rodriguez-Pla et al., 2014</xref>; <xref ref-type="bibr" rid="bib72">Phipps-Yonas et al., 2008</xref>). In other studies, however, a pretreatment with IFN-α diminishes the responses to the following stimulation, resulting in a ‘desensitization’ effect (<xref ref-type="bibr" rid="bib83">Scagnolari and Antonelli, 2018</xref>; <xref ref-type="bibr" rid="bib82">Sarasin-Filipowicz et al., 2009</xref>; <xref ref-type="bibr" rid="bib54">Makowska et al., 2011</xref>). To resolve this paradox, we combined time-lapse imaging, microfluidics, and computational modeling to track and quantify JAK-STAT signaling and downstream gene expression in single human epithelial cells. We revealed that a cell cycle-gated negative feedback loop functions to decode IFN pretreatments with different durations and induce differential single-cell responses, reconciling the opposing results from previous studies. Our findings unravel the important role of the dynamics of IFN pretreatments on modulating cellular responses, suggesting that optimizing administration timing may help boosting the effectiveness of IFN treatment.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>IFN-α pretreatments confer opposite effects depending on their durations</title><p>IFN-α activates the JAK-STAT pathway and upregulates the expression of IFN-stimulated genes (ISGs), initiating an acute inflammatory response to limit pathogen spread. Recent studies found that individual cells respond to IFNs in a highly heterogeneous manner, both in vitro (<xref ref-type="bibr" rid="bib19">Czerkies et al., 2018</xref>; <xref ref-type="bibr" rid="bib77">Rand et al., 2012</xref>; <xref ref-type="bibr" rid="bib70">Patil et al., 2015</xref>) and in vivo (<xref ref-type="bibr" rid="bib61">Miao et al., 2010</xref>; <xref ref-type="bibr" rid="bib91">Stifter et al., 2019</xref>). Therefore, traditional assays that measure averaged responses across populations at static time points may not be able to accurately characterize cells’ responses to IFNs. To monitor the dynamics of JAK-STAT signaling at the single-cell level, we constructed a reporter cell line in HeLa cells, in which <italic>STAT1</italic> was C-terminally tagged with mCherry at its native locus using CRISPR/Cas9. In addition, to monitor downstream gene expression, we inserted a yellow fluorescent protein (YFP) under the endogenous promoter of a representative ISG <italic>IRF9</italic> (P<italic><sub>IRF9</sub></italic>), with a translational skip spacer (P2A) between the reporter and the <italic>IRF9</italic> coding region (<xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1, A–C</xref>). We chose <italic>IRF9</italic> because it has been well defined as one of the major early response ISGs and it encodes a key component of the ISGF3 complex (<xref ref-type="bibr" rid="bib14">Cheon et al., 2013</xref>; <xref ref-type="bibr" rid="bib99">Tsuno et al., 2009</xref>). Using this reporter cell line and time-lapse microscopy, we were able to simultaneously track nuclear translocation of STAT1 and downstream <italic>IRF9</italic> expression in a large number of single cells (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). We observed a rapid nuclear translocation (within ~0.5 hr) of STAT1 followed by a gradual increase in P<italic><sub>IRF9</sub></italic>-driven gene expression in response to IFN-α stimulation (<xref ref-type="fig" rid="fig1">Figure 1B and C</xref>; <xref ref-type="video" rid="video1">Video 1</xref>), consistent with traditional western blotting results (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1, D</xref>). For each single cell, we quantified the nuclear to cytoplasmic ratio of STAT1, which resembles STAT1 activation, and the rate of increase in YFP fluorescence (dYFP/dt) to reflect the P<italic><sub>IRF9</sub></italic>-driven transcriptional activity. STAT1 nuclear translocation correlated temporally with the increase in P<italic><sub>IRF9</sub></italic>-driven transcriptional activity (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). We examined single-cell responses to various doses of IFN-α (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>) and chose 100 ng/ml (10,000 IU/ml), a sub-saturating and clinically relevant (<xref ref-type="bibr" rid="bib95">Tarhini et al., 2012</xref>) concentration, for the following analyses.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>IFN-α pretreatments with different durations lead to opposite effects to the second stimulation.</title><p>(<bold>A</bold>) Schematic of HeLa reporter cell line engineered using CRISPR/Cas9 (top). <italic>STAT1</italic> was tagged with mCherry at C-terminus to monitor the translocation and expression. The coding sequence for P2A-YFP was inserted at the C-terminus of <italic>IRF9</italic> coding sequence to generate a transcription reporter (P<sub>IRF9</sub>). A simplified diagram of the IFN-α pathway components that can be monitored using the reporter cell line (bottom). (<bold>B</bold>) Time lapse images of a representative cell treated with 100 ng/ml IFN-α for 48 hrs. Scale bar: 20 μm. The time traces of nuclear/cytoplasmic STAT1-mCherry and P<italic><sub>IRF9</sub></italic>-YFP signals of the cell are shown on the right. Vertical dashed lines represent cell divisions. (<bold>C</bold>) Averaged time traces of nuclear/cytoplasmic STAT1-mCherry, P<italic><sub>IRF9</sub></italic>-YFP, and the time derivative of P<italic><sub>IRF9</sub></italic>-YFP (dYFP/dt) (n = 257 cells). Data are represented as the mean (solid lines) and <underline>+</underline> standard deviation (SD) (shaded areas). (<bold>D</bold>) Schematic of IFN-α pretreatment experiments (top). Cells were pretreated with 100 ng/ml IFN-α for 0, 2, 10 and 24 hrs followed by 8 hrs of break time and re-stimulated with 100 ng/ml IFN-α for an additional 10 hrs. Bottom: A diagram of the microfluidic set-up. Two syringes filled with culture medium with or without IFN-α were connected to programmable Arduino-controlled valves that control the duration of IFN-α treatments. Images were captured every 5 min throughout the entire experiment that lasted for a total of 52 hr. (<bold>E</bold>) Averaged time traces of P<italic><sub>IRF9</sub></italic>-driven YFP induction (left) and the rate of induction (dYFP/dt, right) in response to the second IFN-α treatment under different pretreatment conditions. For P<italic><sub>IRF9</sub></italic>-YFP induction, the baselines at the beginning of the second stimulation were normalized to the same level for the comparison of induction levels under different pretreatment conditions. Results were from at least three independent experiments. (<bold>F</bold>) Amounts of P<italic><sub>IRF9</sub></italic>-YFP induction by the second IFN-α stimulation under different pretreatment conditions were shown in bar graph (left) and violin plot (right). The bar showed the averages from three independent experiments, represented as mean <underline>+</underline> standard error of the mean (SEM). The differences between the pretreatment conditions and the control are all statistically significant (p&lt;0.001). The violin plots showed the distributions of single-cell responses under different pretreatment conditions. The violin plots cover single-cell data from three independent experiments.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Cell line construction and validation.</title><p>(<bold>A</bold>) Illustration of cell line construction steps. Full detail was described in Materials and methods. Fluorescent reporters introduced and the targeted genes are shown. In each step, homogenous clones grew from single cells were carefully validated with PCR and sequencing to determine correct integration and homozygosity. Only one positive clone was selected to proceed with the next step. (<bold>B</bold>) Schematics of the <italic>ACTB</italic> (top), <italic>STAT1</italic> (middle) and <italic>IRF9</italic> (bottom) tagged loci. Sequences of the gRNA along with the recognition direction and the synonymous substitutions to avoid Cas9 recognition are shown. Targeted integration loci and the design of the donor DNA with indicated homology arms along with the inserts are also shown. (<bold>C</bold>) Representative images of the reporter cell line in response to IFN-α. Cells were treated without or with 100 ng/ml IFN-α for 48 hrs. Scale bar: 20 μm. (<bold>D</bold>) Time course western blots showing the dynamics of phosphorylation (pY701) and expression of STAT1, and the dynamics of IRF9 expression in the reporter cell line. Cells were treated with 100 ng/ml IFN-α for indicated times, harvested and lysed for immunoblotting with indicated antibodies. The dynamics of the endogenous protein phosphorylation and expression, measured using immunoblotting, are similar to those measured using fluorescence microscopy (compare with <xref ref-type="fig" rid="fig1">Figure 1C</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Dose-dependent responses to IFN-α treatment.</title><p>Time traces of nuclear to cytoplasmic ratio for STAT1-mCherry, STAT1-mCherry fluorescence, and P<italic><sub>IRF9</sub></italic>-YFP fluorescence in response to different concentrations (ng/ml) of IFN-α, as indicated. Averages of single-cell traces were shown.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig1-figsupp2-v1.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Dose dependence of desensitization to IFN-α treatment.</title><p>Bar graphs showing the amounts of P<italic><sub>IRF9</sub></italic>-YFP induction to the second IFN input (100 ng/ml) in WT (A - C) and USP18-KD (D – F), pretreated with different concentrations of IFN-α for different durations, as indicated. The results were normalized to the non-pretreatment condition (control). Error bars represent standard deviations of single cells.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig1-figsupp3-v1.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 4.</label><caption><title>Dependence of desensitization effects on the break time.</title><p>Bar graphs showing the amounts of P<italic><sub>IRF9</sub></italic>-YFP induction to the second IFN input followed by different break time durations. Cells were pretreated with 100 ng/ml IFN-α for 24 hrs or not pretreated (control), washed with PBS three times and stimulated with 100 ng/ml IFN-α. The average P<italic><sub>IRF9</sub></italic>-YFP induction was normalized to the non-pretreatment control. Error bars represent standard deviations of single cells.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig1-figsupp4-v1.tif"/></fig></fig-group><media id="video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-58825-video1.mp4"><label>Video 1.</label><caption><title>Response of the dual reporter cell line to 100 ng/ml IFN-α treatment.</title><p>The image sequence was acquired for 50 hrs in which the first 2 hr were before the addition of IFN-α. The NLS-2xiRFP nuclear marker is shown in red and is merged with phase images of the cells. STAT1-mCherry and P<italic><sub>IRF9</sub></italic>-YFP in the same cells are also shown. Movie is shown at 50 frames/second.</p></caption></media><p>To examine the responses to repetitive IFN-α stimulation, we employed a previously reported microfluidic device designed for mammalian cell culturing (<xref ref-type="bibr" rid="bib41">Kolnik et al., 2012</xref>). The device features rapid cell loading by on-chip vacuum and long-term cell culturing in chambers that are isolated from shear stress. In this study, we modified the device to enable constant flows for medium refreshing and computer-programmed dynamic control of IFN inputs (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Using this device, we first exposed the cells to a pulse of IFN-α pretreatment with different durations, followed by an 8-hr break time with the normal medium. We then imposed a second 10-hr IFN-α treatment and evaluated single-cell responses. The device was integrated with time-lapse microscopy to allow tracking of a large number of single cells throughout the experiments (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). We found that a 2- or 10-hr pretreatment accelerated and enhanced the transcriptional response to the second IFN-α input, as indicated by increased induction rates and levels of the P<italic><sub>IRF9</sub></italic>-driven reporter, compared to the control without pretreatment (<xref ref-type="fig" rid="fig1">Figure 1E and F</xref>; compare green and blue curves/bars with black ones). Intriguingly, a 24-hr pretreatment, however, dramatically decreased the transcriptional response to the second input (<xref ref-type="fig" rid="fig1">Figure 1E and F</xref> compare red curves/bars with black ones). Therefore, a pretreatment of IFN-α, depending on its duration, could lead to opposite effects on the responses to the subsequent input. A short pretreatment induces a priming effect, whereas a prolonged pretreatment triggers desensitization. We also examined how changing the dose of IFN pretreatment impacts the effect on the response to the second input and found that a dose higher than 10 ng/ml is required for desensitization in 24-hr pretreatment (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3, A–C</xref>). Furthermore, we tested how the break time between pretreatment and second stimulation influences desensitization and found that the effect of desensitization decreased as a function of break time (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>).</p></sec><sec id="s2-2"><title>USP18 is responsible for desensitization induced by the prolonged IFN-α pretreatment</title><p>We next considered the mechanisms underlying the opposite effects induced by IFN pretreatments. Previous studies have demonstrated that the priming effect can be attributed to the expression induction of IRF9, STAT1 and STAT2, which are components of ISGF3 transcriptional complex that mediates IFN-driven gene expression (<xref ref-type="bibr" rid="bib14">Cheon et al., 2013</xref>), and IFN-induced chromatin modifications (<xref ref-type="bibr" rid="bib37">Kamada et al., 2018</xref>). To determine the mechanism of desensitization caused by the prolonged pretreatment, we use a short hairpin RNA (shRNA) to knock-down the expression of ubiquitin-specific peptidase 18 (USP18), a major negative regulator of JAK-STAT signaling that we identified previously (<xref ref-type="bibr" rid="bib103">Zou et al., 2007</xref>; <xref ref-type="bibr" rid="bib40">Kim et al., 2008</xref>; <xref ref-type="bibr" rid="bib79">Ritchie et al., 2004</xref>; <xref ref-type="bibr" rid="bib55">Malakhova et al., 2003</xref>), in the reporter cell line (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>, <italic>USP18-KD</italic>). <italic>USP18</italic> is transcriptionally upregulated by IFN treatment and exerts inhibition of IFN-α signaling at the receptor level, forming a negative feedback loop (<xref ref-type="bibr" rid="bib82">Sarasin-Filipowicz et al., 2009</xref>; <xref ref-type="bibr" rid="bib23">François-Newton et al., 2011</xref>; <xref ref-type="bibr" rid="bib3">Arimoto et al., 2017</xref>; <xref ref-type="bibr" rid="bib56">Malakhova et al., 2006</xref>).</p><p>We found that a 24-hr IFN-α pretreatment substantially diminished STAT1 nuclear translocation in WT cells upon the second IFN input, whereas 2-hr or 10-hr pretreatment shows a modest effect (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, ‘WT’; <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2, A and B</xref>). However, this desensitization effect was abolished when USP18 expression was knocked down (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, ‘<italic>USP18-KD</italic>’; <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2, C and D</xref>). Furthermore, in accord with STAT1 nuclear translocation, IFN-α pretreatments boosted the transcriptional responses in <italic>USP18</italic>-KD cells upon the second input, exhibiting priming effects independent of their durations or doses (<xref ref-type="fig" rid="fig2">Figure 2</xref>, B and C; <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3, D–F</xref>). These results indicate that USP18 is required for desensitization. We also examined the role of suppressors of cytokine signaling 1 (SOCS1), another negative regulator of JAK-STAT signaling (<xref ref-type="bibr" rid="bib51">Liau et al., 2018</xref>). In contrast to <italic>USP18-KD</italic>, knocking down <italic>SOCS1</italic> (<italic>SOCS1-KD</italic>) did not affect the desensitization of STAT1 nuclear translocation by the prolonged IFN pretreatment (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>). Moreover, to determine how USP18-mediated desensitization influences the antiviral effect of IFN-α treatment, we examined viral replication in WT and <italic>USP18-KD</italic> with or without 24-hr IFN-α pretreatment. We found that the IFN-α pretreatment resulted in a much more dramatic repression of viral replication in <italic>USP18-KD</italic>, ~15 times more effective than in WT (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>), indicating that USP18-mediated desensitization attenuates the antiviral effect of prolonged IFN-α pretreatment.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>USP18 mediates desensitization induced by the prolonged IFN-α pretreatment.</title><p>(<bold>A</bold>) Representative time-lapse images of STAT1 nuclear translocation in response to the second IFN-α treatment under different pretreatment conditions in WT cells (top) and <italic>USP18</italic>-KD (bottom). (<bold>B</bold>) Averaged time traces of P<italic><sub>IRF9</sub></italic>-driven YFP induction (left) and the rate of induction (dYFP/dt, right) in <italic>USP18</italic>-KD cells in response to the second IFN-α treatment under different pretreatment conditions. (<bold>C</bold>) Amounts of P<italic><sub>IRF9</sub></italic>-YFP induction in <italic>USP18</italic>-KD cells by the second IFN-α stimulation under different pretreatment conditions were shown in bar graph (left) and violin plot (right). The bar showed the averages from three independent experiments, represented as mean <underline>+</underline> standard error of the mean (SEM). The differences between the pretreatment conditions and the control are all statistically significant (p&lt;0.001). The violin plots showed the distributions of single-cell responses under different pretreatment conditions. The violin plots cover single-cell data from three independent experiments.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Validation of the <italic>USP18</italic>-KD cell line.</title><p>(<bold>A</bold>) Western blots of USP18 expression in WT and <italic>USP18</italic>-KD cells. Cells were treated with 100 ng/ml IFN-α for indicated times, harvested and lysed for immunoblotting with the USP18 antibody. Time traces of nuclear to cytoplasmic ratio for STAT1-mCherry (<bold>B</bold>) and P<italic><sub>IRF9</sub></italic>-YFP fluorescence (<bold>C</bold>) in WT (black) and <italic>USP18</italic>-KD (red) in response to IFN-α. Averages of single cell traces were shown. The shaded area represents ± SD. (<bold>D</bold>) Averaged cell cycle lengths of WT and <italic>USP18</italic>-KD. Cell divisions were identified in individual cells and the lengths between cell divisions were quantified. Error bars represent standard deviations of single cells.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Quantification of USP18-mediated desensitization in STAT1 nuclear translocation.</title><p>(<bold>A</bold>) Averaged time traces of nuclear/cytoplasmic STAT1-mCherry in WT in response to the second IFN-α treatment under different pretreatment conditions (depicted in <xref ref-type="fig" rid="fig1">Figure 1D</xref>). (<bold>B</bold>) Violin plot shows the single-cell distributions of the peak values of nuclear/cytoplasmic STAT1-mCherry traces in WT under different pretreatment conditions. Black line represents the mean value of single-cell responses. (<bold>C</bold>) Averaged time traces of nuclear/cytoplasmic STAT1-mCherry in <italic>USP18</italic>-KD in response to the second IFN-α treatment under different pretreatment conditions. (<bold>D</bold>) Violin plot shows the single-cell distributions of the peak values of nuclear/cytoplasmic STAT1-mCherry traces in <italic>USP18</italic>-KD under different pretreatment conditions.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig2-figsupp2-v1.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>SOCS1 does not mediate the desensitization of STAT1 nuclear translocation upon IFN stimulation.</title><p>(<bold>A</bold>) Quantitative PCR results comparing <italic>SOCS1</italic> expression in WT (back) and <italic>SOCS1</italic>-KD (red). The data was normalized to WT without IFN-α treatment. The knockdown efficiency (73.71%) was calculated as the relative <italic>SOCS1</italic> induction upon IFN-α treatment in <italic>SOCS1</italic>-KD and WT. Error bars represent ± SEM from three replicates. (<bold>B</bold>) Representative time-lapse images of STAT1 nuclear translocation upon the second IFN-α treatment in WT cells (top), <italic>SOCS1</italic>-KD (middle) and <italic>USP18</italic>-KD (bottom) cells. Cells were pretreated with 100 ng/ml IFN-α for 24 hrs followed by 8 hrs of break time and re-stimulated for 12 hrs. Scale bar: 20 μm. (<bold>C</bold>) Right: Averaged time traces of nuclear/cytoplasmic STAT1-mCherry in WT cells (red), <italic>SOCS1</italic>-KD (green) and <italic>USP18</italic>-KD (blue) cells in response to the second IFN-α treatment. Left: Violin plot shows the single-cell distributions of the peak values of nuclear/cytoplasmic STAT1-mCherry traces in WT cells (red), <italic>SOCS1</italic>-KD (green) and <italic>USP18</italic>-KD (blue) cells. Results were quantified from the experiments in panel B.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig2-figsupp3-v1.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 4.</label><caption><title>Vesicular stomatitis virus (VSV) replication in WT and <italic>USP18</italic>-KD cells with and without 24-hr IFN-α pretreatment.</title><p>Cells with or without a 24-hr pretreatment of 100 ng/ml IFN-α and an 8-hr break time were infected with 2500 PFU (plaque forming units) of VSV. After 18 hrs, viral supernatant was collected and titered. Error bars represent ± SEM, n = 3. Note that the y-axis starts with 100 PFU/well as it is the limit of detection of our method.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig2-figsupp4-v1.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Computational modeling suggests a delayed negative feedback loop through USP18</title><p>Based on our experimental results, we postulated that the opposite effects induced by short versus prolonged pretreatment inputs might be caused by different expression kinetics of ISGF3 components and USP18: a short input is sufficient to trigger ISGF3 expression and thereby the priming effect, whereas a prolonged input is required to induce USP18 expression and hence desensitization. To test this hypothesis in silico, we devised a simple computational model, which is composed of two ordinary differential equations that govern the expression of <italic>IRF9</italic>, an ISGF3 component, and <italic>USP18</italic>. In this model, IRF9 and USP18 act as the positive and the negative feedback regulators of the JAK-STAT pathway, respectively. Another major difference is that, as we proposed above, the upregulation of <italic>USP18</italic> expression features a delayed kinetics and hence requires a continuous IFN stimulation that lasts longer than the delay time τ, whereas the upregulation of <italic>IRF9</italic> initiates immediately upon the IFN treatment (<xref ref-type="fig" rid="fig3">Figure 3A</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>; see Materials and methods for details).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>A kinetic model suggests a delayed negative feedback loop through USP18.</title><p>(<bold>A</bold>) A diagram for the simple kinetic model of the IFN-driven gene regulatory network. (<bold>B</bold>) Fitting errors between simulations and the data with different assigned values of the delay time in USP18 upregulation. (<bold>C</bold>) Amounts of P<italic><sub>IRF9</sub></italic>-YFP induction by the second IFN-α stimulation under different pretreatment conditions, from experimental data (solid bars) and model simulations with the best-fit parameters (open bars). Data were from <xref ref-type="fig" rid="fig1">Figure 1F</xref> and were normalized to the non-pretreatment condition (control). (<bold>D</bold>) Schematic of experimental design with repetitive IFN pulses versus a sustained IFN input. (<bold>E</bold>) Model prediction of the responses to pulsatile versus sustained IFN inputs in the presence and absence of USP18. Results were normalized to the amount of induction to the pulsatile IFN input in WT. (<bold>F</bold>) Experimental data of the responses to pulsatile versus sustained IFN inputs in WT and <italic>USP18</italic>-KD cells. The error bars represent standard deviations of single-cell data.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Model fitting results and the parameter analysis.</title><p>(<bold>A</bold>) A diagram for the simple kinetic model of the IFN-driven gene regulatory network with reaction parameters labeled. (<bold>B</bold>) Fitting results with different delay times. The model fitting results (solid lines) were shown for delay times from 1 to 20 hrs while keeping all the other parameters free (<xref ref-type="fig" rid="fig3">Figure 3B</xref>) and were compared with experimental data (solid circles) under different pretreatment conditions. The delay time of 8 hrs gave smallest error between simulation and data (dashed line). (<bold>C</bold>) Model simulation of the time trace of IRF9 induction in response to 100 ng/ml IFN-α. The model was fit to the end point data from pretreatment experiments with different durations, as well as the time trace data of IRF induction to IFN stimulation. The simulated time trace from the best-fit parameters were shown as the dashed line. The data were from <xref ref-type="fig" rid="fig1">Figure 1C</xref> and were represented as the mean (yellow solid lines) and + / - standard deviation (SD) of single cells (shaded areas). (<bold>D</bold>) Sensitivity analysis of the parameter values. For each parameter, its value was changed across a wide range, while all the other parameters remained at the best-fit values. The simulated results (solid lines) were shown and compared with experimental data (solid circles) under different pretreatment conditions. The dashed line represents the best-fit value. (<bold>E</bold>) Roles of the positive and feedback loops on model performance. (<bold>i</bold>) Original model with both positive and negative feedback loops, (ii) model without positive feedback loop, and (iii) model without negative feedback loop were compared and Akaike information criterion (AIC) was computed using the best-fit parameter set for each model and was shown in the figure. Experimental data (solid bars) and model simulations with the best-fit parameters (open bars) for P<italic><sub>IRF9</sub></italic>-YFP induction by the second IFN-α stimulation under different pretreatment conditions were shown for each model. Data were from <xref ref-type="fig" rid="fig1">Figure 1F</xref> and were normalized to the non-pretreatment condition (control).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Pulsatile IFN-α treatment induces higher ISG expression in single cells.</title><p>(<bold>A</bold>) The violin plots showing single-cell distributions of P<italic><sub>IRF9</sub></italic>-YFP induction upon 5 × 8-hr pulsatile (blue) or 40-hr sustained (red) IFN-α treatments in WT (top) and <italic>USP18</italic>-KD (bottom) cells. The normalized mean levels of P<italic><sub>IRF9</sub></italic>-YFP induction were 1 (WT, pulsatile), 0.6204 (WT, sustained), 1 (<italic>USP18</italic>-KD, pulsatile), and 1.0796 (<italic>USP18</italic>-KD, sustained), respectively. The coefficients of variance (CVs) for <italic>IRF9</italic> induction were 0.1846, 0.1953, 0.2419, and 0.2273, respectively. (<bold>B</bold>) Scatterplots showing STAT1-mCherry versus P<italic><sub>IRF9</sub></italic>-YFP induction in single cells in response to 5 × 8 hr pulsatile or 40-hr sustained IFN-α treatments in WT (top) and <italic>USP18</italic>-KD (bottom) cells. Fluorescent signals without IFN-α treatment were used as control.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig3-figsupp2-v1.tif"/></fig></fig-group><p>This model was able to reproduce the results from pretreatment experiments, where the priming effect dominates for the short pretreatments (2- and 10-hr pretreatments) and the desensitization effect dominates when the pretreatment duration increases to 24-hr (<xref ref-type="fig" rid="fig3">Figure 3C</xref>; the data from <xref ref-type="fig" rid="fig1">Figure 1F</xref>), and positive and negative feedback loops are both important for these effects (parameter sensitivity analysis and model comparison are shown in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1, D and E</xref>). To investigate the effect of the delay in <italic>USP18</italic> upregulation, we altered the delay time from 1 to 20-hr while keeping all the other parameters free. By fitting the model to the data for each assigned delay time, we found that the fitting error (between simulations and data) reaches the minimum when the delay time is 8 hrs (<xref ref-type="fig" rid="fig3">Figure 3</xref>, B and C; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1, B–E</xref>). These analyses supported the hypothesis about a substantial delay in <italic>USP18</italic> upregulation. The model further predicted that repetitive transient IFN inputs that are shorter than the delay time could be less able to induce the USP18-mediated negative feedback loop and hence could lead to a higher transcriptional response than that induced by a prolonged input with the same total treatment time. For example, pulsatile inputs with 5 × 8-hr pulses could produce a higher transcriptional response than that induced by a 40-hr sustained input, and the difference should be USP18-dependent (<xref ref-type="fig" rid="fig3">Figure 3</xref>, D and E). This prediction was tested experimentally and a higher transcriptional response, indicated by the P<italic><sub>IRF9</sub></italic>-driven reporter, was observed when 5 × 8-hr IFN pulses were given, compared to that induced by a single 40-hr treatment. Furthermore, this difference caused by different input dynamics was abolished in <italic>USP18-KD</italic> cells (<xref ref-type="fig" rid="fig3">Figure 3F</xref>; <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>).</p><p>In summary, our modeling results suggest that a prolonged input is required to initiate <italic>USP18</italic> upregulation. Therefore, when the input duration is short, the ISGF3-mediated-positive feedback loop dominates the regulation of JAK-STAT pathway, conferring the priming effect to subsequent stimulation. Once the input duration is prolonged enough to induce USP18 upregulation, the negative regulation by USP18 overrides the positive regulation by ISGF3, resulting in desensitization.</p></sec><sec id="s2-4"><title>The kinetics of <italic>USP18</italic> upregulation by IFN is heterogeneous in single cells</title><p>To test our model directly, we set out to compare the expression kinetics of <italic>IRF9</italic> and <italic>USP18</italic> in living cells. To this end, we built upon the dual reporter cell line constructed in <xref ref-type="fig" rid="fig1">Figure 1A</xref> and inserted a cyan fluorescent protein (CFP) with a nuclear localization signal (NLS) under the endogenous <italic>USP18</italic> promoter (P<italic><sub>USP18</sub></italic>) with a P2A spacer between the reporter and the <italic>USP18</italic> coding region (<xref ref-type="fig" rid="fig4">Figure 4A</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). This cell line enabled us to simultaneously track the kinetics of P<italic><sub>IRF9</sub></italic> and P<italic><sub>USP18</sub></italic>-driven gene expression in the same cells.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Heterogeneous delays in <italic>USP18</italic> upregulation by IFN were observed in single cells.</title><p>(<bold>A</bold>) Schematic of the dual reporter cell line. A coding sequence for NLS-CFP-P2A was inserted endogenously into the N-terminus of <italic>USP18</italic> coding sequence of the previous cell line. IFN-α induces nuclear translocation of STAT1 and upregulation of <italic>IRF9</italic> (P<italic><sub>IRF9</sub></italic>-YFP) and <italic>USP18</italic> (P<italic><sub>USP18</sub></italic>-CFP). (<bold>B</bold>) Representative time traces of P<italic><sub>IRF9</sub></italic>-YFP and P<italic><sub>USP18</sub></italic>-CFP of a single cell in response to IFN-α. Activation time is defined as the time required to initiate the upregulation of the reporters after IFN-α treatment onset. Delay time is defined as the time difference between P<italic><sub>USP18</sub></italic> and P<italic><sub>IRF9</sub></italic> activation times. (<bold>C</bold>) Distributions of P<italic><sub>IRF9</sub></italic> and P<italic><sub>USP18</sub></italic> activation times in single cells (n = 2021 cells). The mean activation times (with 95% confidence interval) of <italic>IRF9</italic> and <italic>USP18</italic> are 7.9008 ± 0.1914 and 12.1620 ± 0.2349 hrs, respectively. The coefficients of variation (CVs) for activation times of <italic>IRF9</italic> and <italic>USP18</italic> are 0.5558 and 0.4429, respectively. (<bold>D</bold>) Distributions of delay times in single cells, quantified from the activation times in C. Cells are classified into two groups based on the delay times. Representative time traces of P<italic><sub>IRF9</sub></italic> and P<italic><sub>USP18</sub></italic> in a single cell from each group are shown (right). Proportion of Group 2 cells (with a delay longer than 10 hrs) is 16.48%. (<bold>E</bold>) Single-cell delay times as a function of the percentages of cell cycle progression upon IFN treatment onset. Left: Diagram illustrating the quantification of the percentage of cell cycle progression at the treatment onset in a single cell. The time between two cell divisions (dashed lines) was considered as the length of one cell cycle. % of cell cycle progression is calculated as the ratio of the time in a cell cycle before IFN-α addition versus the full cell cycle length (100%) (See <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref> for details). Right: Scatterplot of delay time in each single cell versus % of cell cycle progression upon treatment onset. Open circles represent cells in which P<italic><sub>USP18</sub></italic>-CFP upregulation occurred within the same cell cycle as the IFN-α addition. Open triangles represent cells in which P<italic><sub>USP18</sub></italic>-CFP upregulation occurred in the next cell cycle. Red dashed lines indicate the time window for immediate P<italic><sub>USP18</sub></italic> induction. A two-sample t-test was performed for the two populations within and beyond the time window and obtained a p-value&lt;0.001, indicating a significant difference in delay times.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Construction of the cell line with P<italic><sub>USP18</sub></italic>-CFP reporter.</title><p>(<bold>A</bold>) Illustration showing the introduction of P<italic><sub>USP18</sub></italic>-CFP into the dual reporter cell line in <xref ref-type="fig" rid="fig1">Figure 1A</xref>. NLS-CFP-P2A coding sequence was inserted between the promoter and coding sequence of the <italic>USP18</italic> gene to generate a transcriptional reporter. (<bold>B</bold>) Schematic of <italic>USP18</italic> tagged locus. The sequence of the gRNA along with the recognition direction and the synonymous substitutions to avoid Cas9 recognition are shown. The design of the donor DNA with indicated homology arms along with the inserts are shown. (<bold>C</bold>) Representative images of the reporter cell line in response to IFN-α. Cells were treated without or with 100 ng/ml IFN-α for 48 hrs. Scale bar: 20 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Relationships between variations in USP18 upregulation and the heterogeneity in ISGF3 components.</title><p>(<bold>A</bold>) Scatterplots showing the relationship of P<italic><sub>USP18</sub></italic>-CFP expression upon IFN-α treatment with (<bold>i</bold>) the basal level of P<italic><sub>IRF9</sub></italic>-YFP, (ii) P<italic><sub>IRF9</sub></italic>-YFP expression upon IFN-α treatment, (iii) the basal level of STAT1-mCherry, (iv) STAT1-mCherry expression upon IFN-α treatment. (<bold>B</bold>) Scatterplots showing the relationship of P<italic><sub>USP18</sub></italic>-CFP delay times with (<bold>i</bold>) the basal level of P<italic><sub>IRF9</sub></italic>-YFP, (ii) P<italic><sub>IRF9</sub></italic>-YFP expression upon IFN-α treatment, (iii) the basal level of STAT1-mCherry, (iv) STAT1-mCherry expression upon IFN-α treatment. Each dot represents a single cell. Correlation coefficients were calculated and shown in each panel. The single-cell data were from <xref ref-type="fig" rid="fig4">Figure 4</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig4-figsupp2-v1.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>Quantifying the percentage of cell cycle progression upon IFN treatment onset in single cells.</title><p>(<bold>A</bold>) Illustration of measurement of cell mitosis times from time-lapse images. (Top) Representative time-lapse images of cells over multiple cell divisions. (Bottom) The size of nucleus (left) and its absolute time derivatives (right) were plotted for a representative cell (pointed by the yellow arrow) as a function of time. Cell division times (dashed lines) were determined by the peaks in the derivative time trace, which correspond to cytokinesis during mitosis. (<bold>B</bold>) Diagram illustrating the quantification of the percentage of cell cycle progression at the treatment onset in a single cell. The time between two cell divisions (dashed lines) was defined as cell cycle length (T <sub>cell cycle length</sub>). The time between IFN treatment onset time and the next cell division was defined as T<sub>1</sub>. The percentage of cell cycle progression upon IFN treatment onset can be quantified using T <sub>cell cycle length</sub> and T<sub>1</sub>, as shown in the listed formula.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig4-figsupp3-v1.tif"/></fig></fig-group><p>To evaluate the temporal difference in <italic>IRF9</italic> and <italic>USP18</italic> upregulation, we measured and quantified, in each individual cell, the induction kinetics of P<italic><sub>IRF9</sub></italic> and P<italic><sub>USP18</sub></italic> -driven gene expression upon IFN stimulation. We defined the time needed for induction to initiate as ‘activation time’ and the difference between the activation times of <italic>IRF9</italic> and <italic>USP18</italic> as ‘delay time’ (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). We found that, consistent with our model, <italic>IRF9</italic> and <italic>USP18</italic>, although induced by the same upstream JAK-STAT signaling, exhibited strikingly different activation times. P<italic><sub>IRF9</sub></italic>-driven expression was induced with a fast and relatively uniform kinetics among cells; in contrast, P<italic><sub>USP18</sub></italic>-driven expression exhibited a slow and heterogeneous kinetics (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Intriguingly, we quantified the delay times of <italic>UPS18</italic> induction, relative to that of <italic>IRF9</italic>, in single cells and observed a long-tail distribution: about 83.3% of cells showed modest delays in induction (&lt;10 hrs), whereas the other 16.7% cells exhibited more prolonged delays (&gt;10 hrs). We classified these two subpopulations as ‘Group 1’ and ‘Group 2’, respectively (<xref ref-type="fig" rid="fig4">Figure 4D</xref>).</p><p>To determine the source of clonal heterogeneity in <italic>USP18</italic> induction, we analyzed the relationship of USP18 expression with STAT1 or IRF9 expression at the single-cell level and found that the heterogeneity in these upstream components contributed partially to cell-to-cell variation in the expression levels of USP18. However, the delay times of <italic>USP18</italic> upregulation correlated poorly with STAT1 or IRF9 expression (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). We further considered the contribution of the cell cycle stage at IFN treatment onset, as the cell cycle progression has been shown as a major factor that coordinates gene expression (<xref ref-type="bibr" rid="bib52">Liu et al., 2017</xref>). To this end, we quantified the extent of cell cycle progression in each single cell at IFN treatment onset (‘% of cell cycle progression’; <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>) and examined its relationship with the <italic>USP18</italic> delay time in the same cell. We found that cells showed modest delays if the treatment was added at the early phase of their cell cycles (0–35% of the cell cycle). In contrast, in those cells that progressed beyond this phase, the IFN treatment could not initiate USP18 induction until the next cell cycle, resulting in extended delay times proportional to the times needed to reach the next cell cycle (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). These results suggest that the cell-to-cell variability in USP18 delay times may stem from different cell cycle stages among cells at the treatment onset.</p></sec><sec id="s2-5"><title>Cell cycle phases differentially regulate <italic>USP18</italic> expression</title><p>Our results in <xref ref-type="fig" rid="fig4">Figure 4E</xref> suggest that the early phase of cell cycle (0–35% of the cell cycle time), likely the G1 and early S stages, may provide a time window that allows immediate <italic>USP18</italic> induction without significant delays. To directly test that, we imposed chemical perturbations to arrest cells in G1 or G1/S stage and monitored the delay times of <italic>USP18</italic> induction, relative to that of <italic>IRF9</italic>. Specifically, we treated cells with serum starvation (<xref ref-type="bibr" rid="bib46">Langan and Chou, 2011</xref>), lovastatin (<xref ref-type="bibr" rid="bib38">Keyomarsi et al., 1991</xref>; <xref ref-type="bibr" rid="bib33">Javanmoghadam-Kamrani and Keyomarsi, 2008</xref>), and roscovitine (<xref ref-type="bibr" rid="bib42">Kolodziej et al., 2015</xref>), all of which arrested cells in G1 or G1/S stage, prior to the IFN-α treatment. As expected, we observed that cell cycle synchronization substantially reduced the fraction of cells with prolonged delays of <italic>USP18</italic> induction (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). We confirmed that these decreases in the delay times were primarily due to earlier <italic>USP18</italic> upregulation (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title><italic>USP18</italic> expression was differentially regulated by cell cycle phases.</title><p>(<bold>A</bold>) Distributions of delay times in cells treated with different cell cycle perturbations. Cells were serum-starved or treated with lovastatin (5 μM), or with roscovitine (5 μM) for 36 hrs prior to IFN-α treatment. Proportions of Group 2 cells (with a delay longer than 10 hrs) are 16.28% (control), 4.55% (serum starvation), 2.31% (lovastatin), and 0.21% (roscovitine), respectively. (<bold>B</bold>) Schematic of CDK2 activity reporter. Amino acids 994–1087 of human DNA helicase B (DHB) was fused with mCherry. The construct was stably integrated into P<italic><sub>USP18</sub></italic> cell line using lentivirus. The dynamics of nuclear translocation of DHB-mCherry can be used to infer the cell cycle phase. Representative time-lapse images of DHB-mCherry illustrate the inference of cell cycle phases. (<bold>C</bold>) Color maps showing nuclear DHB and P<italic><sub>USP18</sub></italic>-driven gene expression in the same single cells. Each row represents the time trace of a single cell. Cells were grouped into G1 (n = 104), S (n = 124) and G2 (n = 144) based on the nuclear DHB signals (left) at the time of IFN-α addition. For each group, cells were sorted based on P<italic><sub>USP18</sub></italic>-CFP activation time (middle). Right: Distributions of P<italic><sub>USP18</sub></italic>-CFP activation times for each group. (<bold>D</bold>) Distributions of delay times in cells treated with decitabine, a DNA methyltransferase (DMNT) inhibitor. Left: Schematic of the effect of decitabine on DNA methylation and nucleosome occupancy. Right: Distribution of delay times upon decitabine treatment. Cells were cultured with medium in the absence (control) or presence of 100 μM decitabine for 48 hrs prior to 100 ng/ml IFN-α treatment. Cells with delay times longer than 10 hrs are shown in red. Proportions of Group 2 cells (with a delay longer than 10 hrs) are 17.89% (control) and 5.92% (decitabine treated).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Distributions of P<italic><sub>IRF9</sub></italic> and P<italic><sub>USP18</sub></italic> activation times in cells treated with different cell cycle perturbations.</title><p>Cells were serum-starved or treated with lovastatin (5 μM), or with roscovitine (5 μM) for 36 hrs prior to IFN-α treatment. The mean activation times (with 95% confidence interval) of <italic>IRF9</italic> were 8.9482 ± 0.249 hrs (control), 8.2770 ± 0.2310 hrs (serum-starvation), 7.7281 ± 0.1588 hrs (lovastatin), and 9.8733 ± 0.3424 hrs (roscovitine), respectively. The coefficients of variance (CVs) for activation times of <italic>IRF9</italic> were 0.3484, 0.3268, 0.2924, and 0.3868, respectively. The mean activation times (with 95% confidence interval) of <italic>USP18</italic> were 13.7266 ± 0.4215 hrs (control), 11.4415 ± 0.3146 hrs (serum-starvation), 9.6591 ± 0.2210 hrs (lovastatin), and 8.7585 ± 0.2450 hrs (roscovitine), respectively. The CVs for activation times of <italic>USP18</italic> were 0.3844, 0.3220, 0.3257, and 0.3121, respectively. For serum starvation, the mean <italic>IRF9</italic> activation time was decreased by 0.67 hr (−7.5%) and the mean <italic>USP18</italic> activation time was decreased by 2.29 hrs (−16.6%); For lovastatin, the mean <italic>IRF9</italic> activation time was decreased by 1.22 hrs (−13.6%) and the mean <italic>USP18</italic> activation time was decreased by 4.07 hrs (−29.6%); For roscovitine, the mean <italic>IRF9</italic> activation time was increased by 0.93 hr (+10.3%) and the mean <italic>USP18</italic> activation time was decreased by 4.97 hrs (−36.2%). For serum starvation and lovastatin, while both <italic>IRF9</italic> and <italic>USP18</italic> activation times were decreased, <italic>USP18</italic> activation times were decreased to greater extents, resulting in shorter delay times. For roscovitine, <italic>IRF9</italic> activation time was increased and <italic>USP18</italic> activation time was decreased, both of which contribute to the decrease in the delay time. But the change in <italic>USP18</italic> activation time is five times more dramatic than the change in <italic>IRF9</italic> activation time (−4.97 hrs vs +0.93 hr), in agreement with the decrease in <italic>USP18</italic> activation time being a major contributor to the change in the delay time under this condition.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Cell cycle-dependent <italic>USP18</italic> upregulation determined by the FUCCI reporter.</title><p>(<bold>A</bold>) Illustration of how the FUCCI reporter works. The fluorescent signals of chromatin licensing and DNA replication factor 1(Cdt1) and Geminin (Gem) proteins oscillate throughout a cell cycle to infer cell cycle phases. Middle: Images of a representative cell showing the Cdt1 and Gem level at different cell phases. Dynamics of Cdt1 and Gem signals in a single cell are shown along with the cell cycle phase inference. Dashed lines represent cell divisions. (<bold>B</bold>) Color maps of Cdt1, Gem and P<italic><sub>USP18</sub></italic>-CFP expression in the same single cells. Each row represents the time trace of a single cell. Cells were grouped into G1 (n = 451), S (n = 388) and G2 (n = 325) based on Cdt1 and Gem signals (left) at the time of IFN-α addition. For each group, cells were sorted based on P<italic><sub>USP18</sub></italic>-CFP activation time (middle). Right: Distributions of P<italic><sub>USP18</sub></italic>-CFP activation times for each group.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig5-figsupp2-v1.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 3.</label><caption><title>ISG promoters contain a wide range of CpG site numbers and methylation levels.</title><p>(<bold>A</bold>) Histogram showing the numbers of CpG sites at ISG promoters. The promoter region is defined as 1000 bp upstream of the transcription start site. The data are collected from ENCODE database and the list of the 278 ISGs is from Interferome Database. Blue bars: ISG promoters with less than 100 CpG sites; red bars: ISG promoters with more than 100 CpG sites. (<bold>B</bold>) Scatterplot showing the numbers of methylated CpG versus of the numbers of CpG sites for ISG promoters. A CpG site is considered methylated if the methylation level is greater than 50% according to the bisulfide sequencing. Data are from ENCODE database for HeLa cells.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig5-figsupp3-v1.tif"/></fig><fig id="fig5s4" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 4.</label><caption><title>Distributions of P<italic><sub>IRF9</sub></italic> and P<italic><sub>USP18</sub></italic> activation times in cells treated with decitabine.</title><p>Cells were cultured with medium in the absence (control) or presence of 100 μM decitabine for 48 hrs prior to 100 ng/ml IFN-α treatment. The mean activation times (with 95% confidence interval) of <italic>IRF9</italic> were 9.1632 ± 0.2877 hrs (control) and 10.0063 ± 0.3244 hrs (decitabine), respectively. The coefficients of variance (CVs) for activation times of <italic>IRF9</italic> were 0.5289 and 0.5604, respectively. The mean activation times (with 95% confidence interval) of <italic>USP18</italic> were 13.1356 ± 0.3409 hrs (control) and 11.2538 ± 0.3071 hrs (decitabine), respectively. The CVs for activation times of <italic>USP18</italic> were 0.4372 and 0.4718, respectively. The decitabine treatment increased the mean <italic>IRF9</italic> activation time by 0.84 hr (+9.2%) and decreased the mean <italic>USP18</italic> activation time by 1.88 hrs (−14.3%), both of which contribute to the decreased delay time.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig5-figsupp4-v1.tif"/></fig><fig id="fig5s5" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 5.</label><caption><title>The effect of decitabine on cell cycle.</title><p>(<bold>A</bold>) Representative single-cell time traces from decitabine-treated cells. Cells were treated with 100 μM decitabine for 36 hrs prior to being imaged and kept in decitabine throughout the experiment. The FUCCI reporter dynamics (nuclear Cdt1 and Geminin) was tracked in single cells to determine their cell cycle phases and the type of cell cycle arrest. Decitabine-treated cells can be classified into three subgroups: cells with no arrest, cells in G1 arrest, and cells in G2 arrest. (<bold>B</bold>) Pie chart showing the proportions of cells with no arrest, arrested in G1, or arrested in G2 in a population of decitabine-treated cells.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig5-figsupp5-v1.tif"/></fig></fig-group><p>Furthermore, to explicitly determine the cell cycle stages of individual cells at the treatment onset and their relationships with <italic>USP18</italic> induction delays, we generated another reporter cell line in which a cyclin-dependent kinase 2 (CDK2) activity reporter (<xref ref-type="bibr" rid="bib90">Spencer et al., 2013</xref>) is stably integrated, allowing us to infer the cell cycle stages based on the dynamics of DNA helicase B (DHB) nuclear translocation (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). In the same cell line, P<italic><sub>USP18</sub></italic>-driven fluorescent reporter was introduced as described in <xref ref-type="fig" rid="fig4">Figure 4A</xref>. Using this cell line, we classified cells into three groups, G1, S, and G2 cells, based on their cell cycle stages at the IFN treatment onset (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, left). We found that G1 and S cells showed relatively fast <italic>USP18</italic> activation times, whereas a large fraction of G2 cells exhibited a substantial delay in <italic>USP18</italic> induction (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, right). We also employed another cell cycle reporter system called fluorescent ubiquitination-based cell cycle indicator (FUCCI) (<xref ref-type="bibr" rid="bib5">Bajar et al., 2016</xref>) and observed similar patterns to those obtained using the CDK2 activity reporter (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). These results, together with the cell cycle inhibitor data in <xref ref-type="fig" rid="fig5">Figure 5A</xref>, confirmed the influence of cell cycle stages on <italic>USP18</italic> induction. The G1/S stages allow rapid induction of expression induction, but the G2 stage restrains the initiation of gene induction, resulting in a prolonged delay in USP18 expression.</p><p>What is the molecular mechanism underlying the effects of cell cycle stages on <italic>USP18</italic> expression? Previous studies revealed global variations of epigenetic modifications during cell cycle. For instance, DNA methylation decreases in G1 and increases during S and G2 phases (<xref ref-type="bibr" rid="bib11">Brown et al., 2007</xref>; <xref ref-type="bibr" rid="bib101">Woodcock et al., 1986</xref>; <xref ref-type="bibr" rid="bib21">Desjobert et al., 2015</xref>). We postulated that cell cycle progression might influence USP18 expression through variations in DNA methylation. To test this possibility, we first searched the genome-wide DNA methylation profiles of various human cell types. Intriguingly, the promoter of <italic>USP18</italic> contains a large number of CpG sites, which are highly methylated in all the cell types examined. In contrast, the <italic>IRF9</italic> promoter contains less CpG sites and is less methylated (<xref ref-type="bibr" rid="bib43">Komaki, 2018</xref>; <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>). To determine whether the promoter methylation influences <italic>USP18</italic> expression, we treated cells with decitabine (also known as 5-Aza-2’deoxycytidine), a commonly-used DNA methyltransferase inhibitor (<xref ref-type="bibr" rid="bib16">Christman, 2002</xref>; <xref ref-type="bibr" rid="bib64">Momparler, 2005</xref>). We observed that the decitabine treatment reduced the fraction of cells with prolonged delay times in <italic>USP18</italic> induction, which is in part due to earlier <italic>USP18</italic> upregulation (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4</xref>), supporting that the promoter methylation inhibits <italic>USP18</italic> induction (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). This result is consistent with a previous study showing that a decreased promoter methylation leads to increased <italic>USP18</italic> expression in breast cancer (<xref ref-type="bibr" rid="bib94">Tan et al., 2018</xref>). We note that decitabine also leads to cell cycle arrest in G1 or G2 (<xref ref-type="bibr" rid="bib89">Shin et al., 2013</xref>; <xref ref-type="bibr" rid="bib47">Lavelle et al., 2003</xref>). Because only a small fraction of decitabine-treated cells is arrested in G1 (<xref ref-type="fig" rid="fig5s5">Figure 5—figure supplement 5</xref>) and <italic>USP18</italic> induction is largely delayed in G2 (<xref ref-type="fig" rid="fig5">Figure 5C</xref>), the accelerating effect of decitabine on <italic>USP18</italic> expression should be via inhibition of methylation rather than cell cycle arrest. In summary, our results suggested that the cell cycle stages may impact the initiation of USP18 upregulation through modulating the promoter methylation level.</p></sec><sec id="s2-6"><title>Cell-cycle-gated feedback control shapes single-cell responses to repetitive IFN inputs</title><p>Finally, we incorporated the cell-cycle-gated regulation into our model, in replace of the arbitrary delay time, to test whether it is sufficient to account for the experimentally observed delays in <italic>USP18</italic> induction and, consequently, desensitization, at the single-cell level. Based on our experimental results (<xref ref-type="fig" rid="fig4">Figures 4</xref> and <xref ref-type="fig" rid="fig5">5</xref>), we assumed that <italic>USP18</italic> can be induced immediately if the IFN input starts within a fixed time window (G1 and early S phases) of a cell cycle. However, if the input starts outside of the window, cells will have to wait until the open window of the next cell cycle with the delay time equals to the waiting time. We also assumed that the IFN input onset time for each single cell is a random number uniformly distributed within a cell cycle. The length of a full cell cycle was estimated to be 21.82 hrs based on the single-cell time trace measurements (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). The model was fit to the experimentally-determined distribution of USP18 delay times within a cell cycle (<xref ref-type="fig" rid="fig6">Figure 6B</xref>; the data from <xref ref-type="fig" rid="fig4">Figure 4E</xref>) and we obtained an estimate of the open window length to be 7.3 hrs (~33% of 21.82 hrs). Using these experimentally constrained parameters, we then performed stochastic simulations of single-cell responses to different pretreatment experiments, by introducing noise to gene expression reactions. We observed that the 24-hr pretreatment effectively induced <italic>UPS18</italic> upregulation, to a much higher extent than those upon 2-hr and 10-hr pretreatments. Importantly, as shown in <xref ref-type="fig" rid="fig6">Figure 6C</xref>, the higher levels of USP18 expression by the prolonged pretreatment lead to reduced IRF9 induction upon the second stimulation at the single-cell level, qualitatively in agreement with our experimental data (<xref ref-type="fig" rid="fig6">Figure 6D</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Stochastic simulations with the cell-cycle gated feedback control reproduced single-cell responses to IFN pretreatments with different durations.</title><p>(<bold>A</bold>) A diagram for the simple model of the IFN-driven gene regulatory network that incorporates the cell cycle gating of USP18 upregulation. (<bold>B</bold>) Cell-cycle-dependent delay times in the model determined by experimental data from <xref ref-type="fig" rid="fig4">Figure 4E</xref>. (<bold>C</bold>) Scatterplot showing the simulated responses under different pretreatment conditions. Stochastic simulations were performed for 400 times for each condition. In the scatterplot, each circle represents a single run with <italic>IRF9</italic> induction in response to the second IFN-α treatment versus <italic>USP18</italic> expression by the pretreatment. (<bold>D</bold>) Scatterplot showing the single-cell responses under different pretreatment conditions, from experimental data. P<sub>USP18</sub>-CFP expression was measured at the end of the breaktime and the induction of P<sub>IRF9</sub>-YFP was measured 34 hrs after the second IFN-α input was added.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58825-fig6-v1.tif"/></fig><p>Taken together, our experimental and modeling results suggest that the cell cycle gating can give rise to the delay in <italic>USP18</italic> upregulation and USP18-mediated negative feedback loop, wherein the delay time is largely determined by the length of the open window in the cell cycle (a longer open window results in a shorter delay time). When the duration of pretreatment is shorter than or close to the delay time (e.g. 2- or 10-hr pretreatment), <italic>USP18</italic> can only be partially induced in some cells so that the fast-acting positive feedback loop and the priming effect dominate. In contrast, the 24-hr pretreatment, longer than the entire length of a cell cycle, can fully induce USP18-mediated negative feedback in most cells regardless of their cell cycle stages at treatment onset, resulting in desensitization to subsequent stimulation. In this way, key regulatory processes can be compartmentalized temporally by the cell cycle to decode dynamically varying signals.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>IFN signaling is vital in initiating the innate immune response and providing the first line of cellular defense against infection. Although much progress has been made in identifying molecular components that mediate the IFN responses, what remains missing is an understanding about how these components interact and operate dynamically to process varying signals and fine-tune the extent and duration of responses. For example, how cells respond to repetitive IFN stimulation remains puzzling, as previous studies led to opposing conclusions (<xref ref-type="bibr" rid="bib44">Kuri et al., 2009</xref>; <xref ref-type="bibr" rid="bib80">Rodriguez-Pla et al., 2014</xref>; <xref ref-type="bibr" rid="bib82">Sarasin-Filipowicz et al., 2009</xref>; <xref ref-type="bibr" rid="bib54">Makowska et al., 2011</xref>). In this study, we used microfluidics and time-lapse imaging to track the responses to repetitive IFN inputs in single human epithelial cells. We found that the effects of IFN pretreatments are governed by a gene regulatory network comprised of a fast-acting positive feedback loop, in part through upregulation of ISGF3 components, and a delayed negative feedback loop mediated by upregulation of USP18. A short pretreatment input can only induce the positive feedback loop, leading to the priming effect , whereas a prolonged pretreatment activates the negative feedback loop that desensitizes the pathway. Our study reconciled the opposing results from previous studies and revealed that the effects of IFN pretreatments depend on their input durations. This dynamics-based regulation stems from coupled feedback loops that act with different kinetics. Regulatory circuits with coupled negative and positive feedback loops have been discovered in many biological processes, and, depending on the specific mechanisms and kinetics, can give rise to various dynamic behaviors, such as sustained oscillations (<xref ref-type="bibr" rid="bib20">Danino et al., 2010</xref>; <xref ref-type="bibr" rid="bib35">Jiang et al., 2017</xref>) and excitable gene expression (<xref ref-type="bibr" rid="bib68">Ori et al., 2018</xref>; <xref ref-type="bibr" rid="bib92">Süel et al., 2006</xref>; <xref ref-type="bibr" rid="bib65">Mönke et al., 2017</xref>). In this study, the coupled feedback system in the JAK-STAT pathway enables a new function of this well-studied network architecture: it serves as a timer that measures the initial input duration and coordinate the temporal order of regulatory processes with opposing effects, leading to differential cellular responses to subsequent stimuli.</p><p>Moreover, through a closer investigation of the delayed negative feedback, we found that cell cycle phases at IFN treatment onset differentially influence USP18 upregulation, resulting in heterogeneous delays in the induction of this signaling suppressor. More specifically, the G1 and early S phases enable an open window for immediate USP18 upregulation upon the IFN treatment. If cells are exposed to IFN when they pass the G1/S phases, the IFN treatment cannot initiate USP18 induction until the G1 phase of the next cell cycle, causing a dramatic delay in the induction kinetics. In this way, individual cells exhibit substantial cell-to-cell variability in their USP18 induction delay times, as observed experimentally (<xref ref-type="fig" rid="fig4">Figure 4D</xref>), which arises from their different cell cycle phases at IFN treatment onset. Delays in the expression of key regulatory factors have been widely observed in signal-dependent transcriptional responses and have been found important for ensuring proper execution of biological functions (<xref ref-type="bibr" rid="bib31">Hoffmann et al., 2002</xref>; <xref ref-type="bibr" rid="bib17">Covert et al., 2005</xref>; <xref ref-type="bibr" rid="bib48">Lemmon et al., 2016</xref>). Mechanisms underlying these delays include extensive nucleosome occupancy at the promoter regions (<xref ref-type="bibr" rid="bib26">Hansen and O'Shea, 2015</xref>; <xref ref-type="bibr" rid="bib87">Sen et al., 2020</xref>) and cascades in gene expression programs (<xref ref-type="bibr" rid="bib39">Killip et al., 2014</xref>). Gene regulatory networks with specific topologies can also give rise to delayed gene expression, enabling filtering of transient inputs (<xref ref-type="bibr" rid="bib88">Shen-Orr et al., 2002</xref>; <xref ref-type="bibr" rid="bib57">Mangan et al., 2003</xref>; <xref ref-type="bibr" rid="bib98">Toettcher et al., 2013</xref>; <xref ref-type="bibr" rid="bib97">Thurley et al., 2018</xref>). The cell cycle gating revealed in this study represents a new mechanism that leads to delayed induction of specific genes upon stimulation. Distinct from other mechanisms, in this scenario, the cell cycle serves as a control hub that connects the expression of key pathway regulators with extracellular and intracellular conditions, enabling potential cross-regulation of IFN signaling by various factors. For example, external serum or nutrient conditions, which influence cell cycle progression, could thereby modulate USP18 expression and impact IFN responsiveness. This mode of regulation may also provide a link between cell cycle stages and the effects of IFNs on cancer cells. For instance, the resistance of cancer stem cells to IFN treatments may be attributed partially to the fact that they spend the majority of time in G0/G1 (<xref ref-type="bibr" rid="bib22">Doherty et al., 2017</xref>), resulting in high USP18 expression and low IFN responsiveness. Along the same line, a recent report showed that IFN in combination with an G2/M inhibitor increased necroptosis in cancer cells (<xref ref-type="bibr" rid="bib24">Frank et al., 2019</xref>), possibly due to delayed USP18 induction.</p><p>We acknowledge that our study only considered the control of specific ISGs, <italic>STAT1</italic>, <italic>IRF9</italic>, and <italic>USP18</italic>, which play crucial regulatory roles in IFN-driven signaling. There are other mechanisms that also contribute to priming or desensitization of the JAK-STAT pathway. For instance, it has been recently shown that acquisition of histone H3 methylation upon IFN pretreatment accelerates the recruitment of RNA polymerase II and transcription factors, leading to primed transcriptional responses to re-stimulation (<xref ref-type="bibr" rid="bib37">Kamada et al., 2018</xref>). For desensitization, the family of SOCS proteins represses JAK-STAT signaling at multiple layers via various mechanisms (<xref ref-type="bibr" rid="bib93">Tamiya et al., 2011</xref>), constituting negative feedback loops in addition to that mediated by USP18. The coupled ISGF3-USP18 feedback system revealed in this study may function together with all the other mechanisms to maintain homeostasis in the responses to varying IFN signals. Further work will be needed to evaluate the relative contributions of different mechanisms and how they coordinate to fine-tune the IFN responsiveness.</p><p>Future studies will also be needed to determine the detailed mechanisms underlying the cell cycle-gated regulation of USP18. Our results suggest that DNA methylation at the promoter region may be involved in mediating the effects of cell cycle on gene expression (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). However, more experiments will be required to directly monitor DNA methylation level over time and measure its effects on chromatin modifications and the recruitments of transcription factors and RNA polymerase II. Intriguingly, ISGs have a wide range of CpG site numbers, and potentially methylation levels, in their promoters. Among the 278 ISGs examined, 114 genes, besides USP18, have more than 100 CpG sites in their promoters (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2, A</xref>). It would be interesting to perform a genome-wide analysis to see whether the cell-cycle-gated regulation can be more generally observed in other ISGs and how this regulatory scheme contributes to the innate immune response at a global level. Furthermore, IFN-α induces proinflammatory and antiviral responses in many types of cells. As our current study has focused only on HeLa cells, it is necessary to extend the study to other non-cancerous epithelial cell lines. In addition, it would be interesting for future studies to examine and compare the dynamics and regulation of IFN-driven signaling and gene expression responses in other cell types, such as macrophages, dendritic cells, natural killer cells, and T cells, all of which are important players in mounting innate and adaptive immune responses. With specialized physiologies and functions, these cells may exhibit largely distinct response dynamics and modes of regulation. A careful investigation along this direction will advance our understanding about how various types of cells utilize the same set of molecular pathways with different kinetics to communicate with one another and coordinate their responses to infection. In addition, our study, and many recent single-cell analyses from other groups (<xref ref-type="bibr" rid="bib34">Jeknić et al., 2019</xref>), highlight the presence of substantial clonal heterogeneity in cellular responses to signals. An open question that deserves extensive further exploration is how these cell-to-cell variabilities contribute to biological functions, in vitro, and more importantly, in vivo, under physiological contexts. Ongoing and future technological advances will enable us to tackle the emerging questions and challenges in single-cell biology, providing a more comprehensive, quantitative, and dynamic view of biological systems.</p><p>Finally, due to the COVID-19 pandemic caused by SARS-CoV-2, there is an urgency in understanding the basic biology of host response to viral infection, which may help the development of clinical strategies against the disease. Latest research revealed that SARS-CoV-2 is especially sensitive to type I IFNs, compared to other coronaviruses, making IFN pretreatment a potential strategy to prevent SARS-CoV-2 infection (<xref ref-type="bibr" rid="bib53">Lokugamage et al., 2020</xref>; <xref ref-type="bibr" rid="bib10">Blanco-Melo et al., 2020</xref>; <xref ref-type="bibr" rid="bib81">Sallard et al., 2020</xref>). Our findings suggested possible ways to enhance the effectiveness of IFNs for future clinical use. For example, repetitive short-term administrations of IFN may lead to less desensitization and a more dramatic effect than prolonged treatments. Alternatively, the combined use of USP18 inhibitors with type I IFNs may substantially boost the effectiveness of IFNs against SARS-CoV-2. Further studies in animal models will be needed to test these strategies and to direct clinical applications for treating the disease.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type <break/>(species) or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional <break/>information</th></tr></thead><tbody><tr><td valign="top">Cell line <break/>(<italic>Homo sapiens</italic>)</td><td valign="top"><italic>HeLa P<sub>ACTB</sub>-NLS-2iRFP-P2A-ACTB</italic></td><td valign="top">This paper</td><td valign="top">NHM003</td><td valign="top">Available upon request from Hao lab</td></tr><tr><td valign="top">Cell line <break/>(<italic>Homo sapiens</italic>)</td><td valign="top"><italic>HeLa P<sub>ACTB</sub>-NLS-2iRFP-P2A-ACTB, P<sub>STAT1</sub>-STAT1-mCherry</italic></td><td valign="top">This paper</td><td valign="top">NHM008</td><td valign="top">Available upon request from Hao lab</td></tr><tr><td valign="top">Cell line <break/>(<italic>Homo sapiens</italic>)</td><td valign="top"><italic>HeLa P<sub>ACTB</sub>-NLS-2iRFP-P2A-ACTB, P<sub>STAT1</sub>-STAT1-mCherry, P<sub>IRF9</sub>-IRF9-P2A-mCitrine</italic></td><td valign="top">This paper</td><td valign="top">NHM025</td><td valign="top">Available upon request from Hao lab</td></tr><tr><td valign="top">Cell line <break/>(<italic>Homo sapiens</italic>)</td><td valign="top"><italic>HeLa P<sub>ACTB</sub>-NLS-2iRFP-P2A-ACTB, P<sub>STAT1</sub>-STAT1-mCherry, P<sub>IRF9</sub>-IRF9-P2A-mCitrine, shRNA USP18</italic></td><td valign="top">This paper</td><td valign="top">NHM026</td><td valign="top">Available upon request from Hao lab</td></tr><tr><td valign="top">Cell line <break/>(<italic>Homo sapiens</italic>)</td><td valign="top"><italic>HeLa P<sub>ACTB</sub>-NLS-2iRFP-P2A-ACTB, P<sub>STAT1</sub>-STAT1-mCherry, P<sub>IRF9</sub>-IRF9-P2A-mCitrine, shRNA USP18 negative control</italic></td><td valign="top">This paper</td><td valign="top">NHM027</td><td valign="top">Available upon request from Hao lab</td></tr><tr><td valign="top">Cell line <break/>(<italic>Homo sapiens</italic>)</td><td valign="top"><italic>HeLa P<sub>ACTB</sub>-NLS-2iRFP-P2A-ACTB, P<sub>STAT1</sub>-STAT1-mCherry, P<sub>IRF9</sub>-IRF9-P2A-mCitrine, shRNA SOCS1</italic></td><td valign="top">This paper</td><td valign="top">NHM031</td><td valign="top">Available upon request from Hao lab</td></tr><tr><td valign="top">Cell line <break/>(<italic>Homo sapiens</italic>)</td><td valign="top"><italic>HeLa P<sub>ACTB</sub>-NLS-2iRFP-P2A-ACTB, P<sub>STAT1</sub>-STAT1-mCherry, P<sub>IRF9</sub>-IRF9-P2A-mCitrine, P<sub>USP18</sub>-NLS-mCerulean-USP18</italic></td><td valign="top">This paper</td><td valign="top">NHM032</td><td valign="top">Available upon request from Hao lab</td></tr><tr><td valign="top">Cell line <break/>(<italic>Homo sapiens</italic>)</td><td valign="top"><italic>HeLa P<sub>ACTB</sub>-NLS-2iRFP-P2A-ACTB, P<sub>USP18</sub>-NLS-mCerulean-USP18, P<sub>CMV</sub>-DHB-mCherry</italic></td><td valign="top">This paper</td><td valign="top">NHM035</td><td valign="top">Available upon request from Hao lab</td></tr><tr><td valign="top">Cell line <break/>(<italic>Homo sapiens</italic>)</td><td valign="top"><italic>HeLa P<sub>ACTB</sub>-NLS-2iRFP-P2A-ACTB, P<sub>USP18</sub>-NLS-mCerulean-USP18, P<sub>CMV</sub>-mCh-Gem1-P2A-CFP-Cdt1</italic></td><td valign="top">This paper</td><td valign="top">NHM036</td><td valign="top">Available upon request from Hao lab</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Cell cultures</title><p>HeLa and HEK293T were ordered from ATCC (ATCC CCL-2 and ATCC CRL-11268, respectively) and tested negative for <italic>Mycoplasma</italic> using <italic>Mycoplasma</italic> detection kit (Southern Biotech). HeLa and HEK293T cells were cultured in Dullbecco minimal essential medium (DMEM: Thermo Scientific HyClone #SH30022FS) supplemented with 10% fetal bovine serum, 4 mM L-glutamine, 100 I.U./ml penicillin and 100 μg/ml streptomycin at 37°C, 5% CO<sub>2</sub> and 90% humidity. The imaging media is phenol red free DMEM (Life Technology-Gibco) with identical supplements as the culture medium. The transfections were performed with 1 μg DNA: 2 μl Fugene HD (Promega E2311) ratio. Cells were seeded at 300,000 cells/well in six-well plate for 18 hrs before transfection. Two days after transfection puromycin was added to the medium at 1 μg/ml, and cells were selected for 2 days. Survival cells were grown for another 7 days before sorted with FACS into 96-well and expanded into monoclonal cell lines.</p></sec><sec id="s4-2"><title>Drug treatments</title><p>Cells were treated with 100 ng/mL recombinant human IFN-α 1a (Prospec: cyt-520). Lovastatin (Selleck Chemicals, S2061) was used at 5 μM and Roscovitine (Sigma-Aldrich, R7772) was used at 5 μM. Decitabine (Sigma-Aldrich, A3656) was used at 100 μM. We note that we did not observe any cell death in the decitabine experiments. In our system, decitabine at 100 μM slowed down cell growth, but did not cause apoptosis at least during the time scales of our experiments. However, we did observe cell death at 200 μM decitabine.</p></sec><sec id="s4-3"><title>Cell line construction</title><p>We followed the CRISPR/Cas9 protocol (<xref ref-type="bibr" rid="bib76">Ran et al., 2013</xref>) to construct the reporter cell line. In general, the gRNAs were designed by online CRISPR tool (<ext-link ext-link-type="uri" xlink:href="http://crispr.mit.edu">http://crispr.mit.edu</ext-link>) and the DNA oligos were ordered from Eurofins Genomics, annealed and cloned into pSpCas9(BB)−2A-Puro (Addgene #48139) vector plasmids. gRNA plasmids were transfected into HEK293T cells and tested for gRNA efficiency using the T7 endonuclease assay. Only the most efficient gRNA was used with the donor DNA. The donor plasmids were constructed using Gibson assembly method. We used site-directed in-vitro mutagenesis to make synonymous substitution in the donor plasmids to avoid gRNA recognition and Cas9 cutting of the linearized donor DNA.</p><p>In more detail, we first developed a nuclear marker cell line by inserting the nuclear localization signal followed by two copies of infrared fluorescent protein (NLS-2xiRFP) (<xref ref-type="bibr" rid="bib67">Ogrodnik et al., 2014</xref>) under the endogenous actin promoter followed by a P2A spacer in HeLa cells. This cell line ensured a constitutive expression without introducing exogeneous strong constitutive promoter and greatly assisted cell segmentation and tracking. Briefly, the gRNA and the linearized donor DNA were transfected into HeLa cells and the transfected cells were screened with 1 μg/ml puromycin for 2 days. The cells were allowed to grow for additional 5 days before sorted by FACS. The fluorescently positive cells were sorted as single cell into 96-well plate. We collected at least 500 single cells. We grew the cells for additional 3 weeks to obtain homogenous clones. On average, about 30% of cells formed colonies and all were screened for fluorescent signal with the microscope. A minimal of 10 clones were then genotyped and checked for homozygosity and correct integration using at least three pairs of primers and confirmed with sequencing. Positive clones were further validated with western blot to ensure correct protein expression. After construction and validation, the engineered single-clonal cell line was assigned a unique identification number, entered in our electronic database, and stored in liquid nitrogen with a cryoprotectant. The same procedure was performed for CRISPR-based tagging the additional genes, <italic>STAT1</italic>, <italic>IRF9</italic> and <italic>USP18</italic> sequentially.</p><p>The knockdown of <italic>USP18</italic> by shRNA was done using retrovirus transduction. We screened the transfected cells with 1 μg/ml puromycin for 5 days and confirmed the presence of the construct in the cells with PCR and confirmed the knock-down of USP18 with western blotting. Similarly, the knockdown of <italic>SOCS1</italic> by shRNA was done using lentivirus transduction, screened and validated with PCR and qPCR.</p><p>For the cell cycle reporter cell lines, we transfected <italic>USP18</italic> CRISPR constructs into the nuclear marker cell line and screened for a correct and homogenous monoclonal clone. We then used lentivirus to stably integrate pCMV-DHB-mCherry or pCMV-mCherry-Geminin(1-110)-P2A-mCitrine-Cdt1(30-120) in pLenti-Puro (Addgene: 39481). Cells were screened with puromycin and sorted by FACS to generate monoclonal cell lines.</p><p>Primers used in this study were listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. Plasmids and cell lines constructed in this study were listed in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref> and Key Resources Table, respectively.</p></sec><sec id="s4-4"><title>Microfluidic and cell culture setup for time-lapse microscopy</title><p>Fabrication of the microfluidic device was conducted as described previously (<xref ref-type="bibr" rid="bib41">Kolnik et al., 2012</xref>). For setting up the microfluidic experiments, HeLa cells were washed with dPBS and detached from the culture dish with 0.25% trypsin EDTA, centrifuged at 200 rcf for 3 min and resuspended with the complete imaging medium at a density of 7–10 million cells per mL. The suspension was loaded into the microfluidic device and allow the cells to adhere for at least 36 hrs in the standard incubator (37°C, 5% CO<sub>2</sub> and 90% humidity). The detail of the loading protocol is described previously (<xref ref-type="bibr" rid="bib41">Kolnik et al., 2012</xref>). The device was set up in a customized chamber with 5% CO<sub>2</sub> and 37°C. The flow of the media was 1 ml/hr and the control of the valves were done with customized Arduino board.</p><p>For experiment performed on 24-well tissue culture plate, cells were seeded at 25,000 cells/well for 18 hrs before the treatments. Cells were washed with PBS and replaced with new medium before setting with the microscope to acquire images.</p></sec><sec id="s4-5"><title>Image acquisition</title><p>Time-lapse images were acquired using a Nikon Ti-E inverted microscope equipped with integrated Perfect-Focus (PFS), Nikon Plan Apochromat Lambda objective lens, and Evolve 512 EMCCD camera (Teledyne Photometrics). Time-lapse imaging was performed with an on-stage incubator equipped with temperature control and humidified 5% CO<sub>2</sub>. Images were taken every 5 min for phase, Cy5.5 and mCherry channel and every 20 min for YFP and 30 min for CFP using Nikon NES element software.</p></sec><sec id="s4-6"><title>Image analysis and single-cell tracking</title><p>Background correction was performed using ImageJ ‘rolling ball’ background subtraction algorithm with 50-pixel radius. Nuclear segmentation was done using the nuclear marker iRFP reporter and then refined by marker-based watershed and the mask was generated. The phase images were used to generate masks for whole-cell segmentation. The masks were applied to other channels to quantify fluorescent intensity. Single-cell segmentation, tracking and quantification were performed using a custom MATLAB code developed in our lab, as described previously (<xref ref-type="bibr" rid="bib49">Li et al., 2017a</xref>; <xref ref-type="bibr" rid="bib50">Li et al., 2017b</xref>).</p></sec><sec id="s4-7"><title>Cell cycle phase inference</title><p>From the single-cell time traces, we used nuclear and cell morphology changes as markers to identify each cell division, since HeLa cells become rounded and non-adherent when dividing. For CDK2 activity reporter, within one cell cycle G1, S and G2 were identified based on the intensity and dynamics of nuclear DHB-mCherry. Similarly, for the FUCCI reporter, G1 phase was classified as the phase between the end of cell division and the time the YFP-Cdt1 signal reaches maximum. S phase began as YFP-Cdt1 signal starts to decline until it intersects with mCherry-Gem1 signal. The rest of the cell cycle was considered the G2 phase.</p></sec><sec id="s4-8"><title>Viral replication assay</title><p>Cells were pretreated with 100 ng/ml IFN-α for 0, 10 or 24 hrs and washed with PBS three times followed by 8 hrs of normal medium. Cells were infected by adding normal medium containing 2500 plaque forming units (PFU) of vesicular stomatitis virus (VSV), which corresponds to a multiplicity of infection (MOI) of ~0.01. Two hours after infection, medium was replaced again with normal medium. Viral supernatant was collected 18 hrs post-infection. Viral titer was quantified by plaque assay on BHK cells.</p></sec><sec id="s4-9"><title>Immunoblotting</title><p>Immunoblotting was performed as previously described in detail (<xref ref-type="bibr" rid="bib3">Arimoto et al., 2017</xref>).</p></sec><sec id="s4-10"><title>Computational modeling</title><sec id="s4-10-1"><title>Deterministic model</title><p>The simplified kinetic model of the gene regulatory network consists of two species, IRF9 and USP18, and they impose positive and negative regulation to gene expression, respectively. The positive regulation by IRF9 is represented by the function <inline-formula><mml:math id="inf1"><mml:mi>p</mml:mi><mml:mi>f</mml:mi></mml:math></inline-formula>:<disp-formula id="equ1"><mml:math id="m1"><mml:mi>p</mml:mi><mml:mi>f</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:mfrac><mml:mrow><mml:mi>I</mml:mi><mml:mi>R</mml:mi><mml:mi>F</mml:mi><mml:mn>9</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>I</mml:mi><mml:mi>R</mml:mi><mml:mi>F</mml:mi><mml:mn>9</mml:mn></mml:mrow></mml:mfrac></mml:math></disp-formula>and the negative regulation by USP18 is represented by the function <inline-formula><mml:math id="inf2"><mml:mi>n</mml:mi><mml:mi>f</mml:mi></mml:math></inline-formula>:<disp-formula id="equ2"><mml:math id="m2"><mml:mi>n</mml:mi><mml:mi>f</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>U</mml:mi><mml:mi>S</mml:mi><mml:mi>P</mml:mi><mml:mn>18</mml:mn></mml:mrow></mml:mfrac></mml:math></disp-formula></p><p>The expression of IRF9 and USP18 are both regulated by interferon (IFN) input and a combination of these two functions, and are governed by the ordinary differential equations (ODEs) below:<disp-formula id="equ3"><mml:math id="m3"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mi>I</mml:mi><mml:mi>R</mml:mi><mml:mi>F</mml:mi><mml:mn>9</mml:mn><mml:mo>=</mml:mo><mml:mi>I</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mo>∙</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>p</mml:mi><mml:mi>f</mml:mi></mml:mrow></mml:mfenced><mml:mo>∙</mml:mo><mml:mi>n</mml:mi><mml:mi>f</mml:mi></mml:math></disp-formula><disp-formula id="equ4"><mml:math id="m4"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mi>U</mml:mi><mml:mi>S</mml:mi><mml:mi>P</mml:mi><mml:mn>18</mml:mn><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>I</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mo>∙</mml:mo><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>u</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>5</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>p</mml:mi><mml:mi>f</mml:mi></mml:mrow></mml:mfenced><mml:mo>∙</mml:mo><mml:mi>n</mml:mi><mml:mi>f</mml:mi></mml:math></disp-formula>where I(t) is the IFN input, taking either 0 or 1. <inline-formula><mml:math id="inf3"><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>u</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is a stepwise function that generates a delay in USP18 upregulation:<disp-formula id="equ5"><mml:math id="m5"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtext> </mml:mtext><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi>u</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mtext> </mml:mtext><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mtext> </mml:mtext><mml:mi>w</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mtext> </mml:mtext><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mtext> </mml:mtext><mml:mi>I</mml:mi><mml:mi>F</mml:mi><mml:mi>N</mml:mi><mml:mtext> </mml:mtext><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi><mml:mi>t</mml:mi><mml:mtext> </mml:mtext><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mtext> </mml:mtext><mml:mo>&lt;</mml:mo><mml:mi>τ</mml:mi></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mtext> </mml:mtext><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>w</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mtext> </mml:mtext><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mtext> </mml:mtext><mml:mi>I</mml:mi><mml:mi>F</mml:mi><mml:mi>N</mml:mi><mml:mtext> </mml:mtext><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>p</mml:mi><mml:mi>u</mml:mi><mml:mi>t</mml:mi><mml:mtext> </mml:mtext><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mtext> </mml:mtext><mml:mo>≥</mml:mo><mml:mi>τ</mml:mi></mml:mtd></mml:mtr></mml:mtable><mml:mo fence="true" stretchy="true" symmetric="true"/></mml:mrow></mml:mrow></mml:mstyle></mml:math></disp-formula>where <inline-formula><mml:math id="inf4"><mml:mi>τ</mml:mi></mml:math></inline-formula> is the delay time of USP18 production.</p><p>During the time scale of our experiments, we observed very modest decays of STAT1, IRF9 and USP18. Therefore, to keep our model simple, we considered only protein production, but not decay. We used the model to quantitatively analyze the USP18 delay time. To this end, we systematically assigned the value of <inline-formula><mml:math id="inf5"><mml:mi>τ</mml:mi></mml:math></inline-formula> to be from 1 to 20 hours, while keeping all the other parameters free. We fit the model to the data for each assigned value of <inline-formula><mml:math id="inf6"><mml:mi>τ</mml:mi></mml:math></inline-formula>. The ODEs were solved using custom MATLAB code based on the basic Euler’s method with dt=0.001. Fitting was done using MATLAB built-in function, <italic>lsqcurvefit</italic>. The time trace data of P<italic><sub>IRF9</sub></italic>-YFP reporter fluorescence under sustained IFN-<inline-formula><mml:math id="inf7"><mml:mi>α</mml:mi></mml:math></inline-formula> stimulation (<xref ref-type="fig" rid="fig1">Figure 1C</xref>) and the data from all the pretreatment experiments (<xref ref-type="fig" rid="fig1">Figure 1F</xref>) were used for the fitting. We found that the fitting error (between simulations and data) reaches the minimum when <inline-formula><mml:math id="inf8"><mml:mi>τ</mml:mi></mml:math></inline-formula> is 8 hours (<xref ref-type="fig" rid="fig3">Figure 3B and C</xref>). We included the fitting results for each delay time in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>. As shown in the figure, shorter delay times resulted in less desensitization effects from the 24-hr pretreatment, whereas longer delay times led to slightly less priming effects from the 2-hr pretreatment, compared with the data. We note that, these fitting analyses supported the hypothesis that there should be a substantial delay in USP18 induction to account for the observed effects, but did not provide sufficient power to quantitatively constrain the value of the delay time. The best-fit parameters are summarized in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>. The simulated time trace using the best-fit parameters was shown in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>. We note that our model, due to its simplicity, has limited capability to reproduce the dynamic response data. Therefore, we weighted more on the endpoint data under different conditions than the time trace data during fitting. The sensitivity analysis all the parameters was included in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>. To evaluate the roles of positive feedback and negative feedback loops on model performance, we compared the performance of three models: (1) the original model with both positive and negative feedback loops, (2) the model without positive feedback loop; and (3) the model without negative feedback loop. To this end, we computed Akaike information criterion (AIC) using the best-fit parameters for each model. The distribution of the data was assumed to be Gaussian, and the likelihood function was computed as:<disp-formula id="equ6"><mml:math id="m6"><mml:mi>L</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mo>∏</mml:mo><mml:mrow><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msqrt><mml:mn>2</mml:mn><mml:mi>π</mml:mi><mml:msup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:msqrt></mml:mrow></mml:mfrac><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mi>y</mml:mi><mml:mo>-</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:msup><mml:mrow><mml:mi>σ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></disp-formula>where y is experimental result and <inline-formula><mml:math id="inf9"><mml:mover accent="true"><mml:mrow><mml:mi>y</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:math></inline-formula> is the predicted result. Akaike information criterion is computed as:<disp-formula id="equ7"><mml:math id="m7"><mml:mi>A</mml:mi><mml:mi>I</mml:mi><mml:mi>C</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mi>k</mml:mi><mml:mo>-</mml:mo><mml:mn>2</mml:mn><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mo>⁡</mml:mo><mml:mo>(</mml:mo><mml:mi>L</mml:mi><mml:mo>)</mml:mo></mml:math></disp-formula>where k is the number of parameters and L is the computed likelihood function. We found that the original model performs better than the other two models with the smallest AIC, suggesting that both positive and negative feedback loops are important for the model to reproduce experimental data (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>).</p><p>We further used the model to predict the responses to repetitive versus sustained IFN inputs. In particular, we simulated the responses to a 5 × 8-hr input and a 40-hr sustained input. We found that the 5 × 8-hr input induced a higher expression of IRF9 than that induced by the 40-hr input, and this difference is USP18-dependent (<xref ref-type="fig" rid="fig3">Figure 3</xref>, D and E). This prediction was validated by experiments, as shown in <xref ref-type="fig" rid="fig3">Figure 3F</xref>.</p><p>All the code in this study is stored at <ext-link ext-link-type="uri" xlink:href="https://github.com/yaj030/2020_Sorn_Elife">https://github.com/yaj030/2020_Sorn_Elife</ext-link> (<xref ref-type="bibr" rid="bib36">Jiang, 2020</xref>; copy archived at <ext-link ext-link-type="uri" xlink:href="https://github.com/elifesciences-publications/2020_Sorn_Elife">https://github.com/elifesciences-publications/2020_Sorn_Elife</ext-link>).</p></sec><sec id="s4-10-2"><title>Incorporation of cell cycle regulation in the model</title><p>As described in the main text, based on the experimental results in <xref ref-type="fig" rid="fig4">Figures 4</xref> and <xref ref-type="fig" rid="fig5">5</xref>, we assumed that USP18 expression can be induced immediately if the IFN input starts within an open window of a cell cycle and the delay time would be 0. However, if the input misses the window, the cell will have to wait until the open window of the next cell cycle and the delay time will equal to the waiting time. The length of a full cell cycle was estimated to be 21.82 hrs based on the experimental data (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). The model was fit to the experimentally-determined distribution of USP18 delay times within a cell cycle (<xref ref-type="fig" rid="fig6">Figure 6B</xref>; the data from <xref ref-type="fig" rid="fig4">Figure 4E</xref>) to obtain an estimate of the open window length as 7.3 hrs. The stochastic simulation was performed with the stochastic differential equations:<disp-formula id="equ8"><mml:math id="m8"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mi>I</mml:mi><mml:mi>R</mml:mi><mml:mi>F</mml:mi><mml:mn>9</mml:mn><mml:mo>=</mml:mo><mml:mi>I</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mo>∙</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>p</mml:mi><mml:mi>f</mml:mi></mml:mrow></mml:mfenced><mml:mo>∙</mml:mo><mml:mi>n</mml:mi><mml:mi>f</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mrow><mml:mi>I</mml:mi><mml:mi>R</mml:mi><mml:mi>F</mml:mi><mml:mn>9</mml:mn></mml:mrow></mml:msub></mml:math></disp-formula><disp-formula id="equ9"><mml:math id="m9"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mi>U</mml:mi><mml:mi>S</mml:mi><mml:mi>P</mml:mi><mml:mn>18</mml:mn><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>I</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mo>∙</mml:mo><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>u</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>5</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>p</mml:mi><mml:mi>f</mml:mi></mml:mrow></mml:mfenced><mml:mo>∙</mml:mo><mml:mi>n</mml:mi><mml:mi>f</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mrow><mml:mi>U</mml:mi><mml:mi>S</mml:mi><mml:mi>P</mml:mi><mml:mn>18</mml:mn></mml:mrow></mml:msub></mml:math></disp-formula>in which, <inline-formula><mml:math id="inf10"><mml:msub><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mrow><mml:mi>I</mml:mi><mml:mi>R</mml:mi><mml:mi>F</mml:mi><mml:mn>9</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="inf11"><mml:msub><mml:mrow><mml:mi>ξ</mml:mi></mml:mrow><mml:mrow><mml:mi>U</mml:mi><mml:mi>S</mml:mi><mml:mi>P</mml:mi><mml:mn>18</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> are white noise terms, representing expression noise for the two species. Both of the two terms are Gaussian random variables with a mean of zero and the standard deviations set to be 250 and 1000, respectively. These values of noise terms were manually chosen from observing the single-cell data in <xref ref-type="fig" rid="fig6">Figure 6D</xref>. The input onset times of single cells within a cell cycle are random numbers uniformly distributed within a cell cycle between 0 to 21.82 hours. <inline-formula><mml:math id="inf12"><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>u</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is no longer a deterministic stepwise function with a fixed delay <inline-formula><mml:math id="inf13"><mml:mi>τ</mml:mi></mml:math></inline-formula>, instead it is a stochastic stepwise function, where the delay <inline-formula><mml:math id="inf14"><mml:mi>τ</mml:mi></mml:math></inline-formula> varies depending on the IFN treatment onset within a cell cycle, as described above. Other parameters are the same as those listed in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>. We simulated the single-cell responses of the pretreatment experiments with different input durations. For each pretreatment condition, we performed 400 simulations where each simulation represented a single cell exposed to the IFN inputs. Our simulated results were plotted as scatter plots in <xref ref-type="fig" rid="fig6">Figure 6C</xref>.</p><p>To compare the simulation results with data, we calculated the correlation coefficients of <italic>IRF9</italic> and <italic>USP18</italic> in <xref ref-type="fig" rid="fig6">Figure 6C</xref> (simulation) and 6D (data), and obtained −0.37 and −0.49, respectively. In addition, we calculated the coefficients of variance (CVs) of single cells for <italic>IRF9</italic> and <italic>USP18</italic> under different pretreatment conditions. For <italic>IRF9</italic>, we obtained 0.44, 0.52, and 0.46 upon 2-hr, 10-hr, and 24-hr pretreatments, respectively, from the simulated results. We obtained 0.28, 0.37, and 0.56 upon 2-hr, 10-hr, and 24-hr pretreatments, respectively, from the data. For <italic>USP18</italic>, we obtained 0.71, 0.59, and 0.24 upon 2-hr, 10-hr, and 24-hr pretreatments, respectively, from the simulated results. We obtained 0.41, 0.49, and 0.35 upon 2-hr, 10-hr, and 24-hr pretreatments, respectively, from the data. Based on these analyses, we conclude that our stochastic simulations can qualitatively reproduce the negative correlation between USP18 expression upon pre-treatment and IRF9 induction by the second stimulation, but cannot quantitatively reproduce the expression levels or the cell-to-cell variance under different conditions.</p></sec></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Dr. Daniel Kaganovich (University Medical Center Gottingen, Germany) for generously providing the plasmids for NLS-iRFPx2 plasmid and Dr. Sabrina Spencer (University of Colorado Boulder) for the DHB-mVenus plasmid. This work was supported by NIH R01 GM111458 (to NH), NIH R01 CA177305 (to D-EZ), NIH R01 CA232147 (to D-EZ), NIH R35 GM133633 and Pew Biomedical Research scholars (to MDD), the DPST training scholarship from the Royal Thai government (to AM), and a T32 training grant GM007240 (to APR).</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Formal analysis, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Primers used in this study.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-58825-supp1-v1.docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Plasmids constructed in this study.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-58825-supp2-v1.docx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Best-fit parameter values of the model.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-58825-supp3-v1.docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-58825-transrepform-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abreu</surname> <given-names>SL</given-names></name><name><surname>Bancroft</surname> <given-names>FC</given-names></name><name><surname>Stewart</surname> <given-names>WE</given-names></name></person-group><year iso-8601-date="1979">1979</year><article-title>Effects on interferon messenger RNA</article-title><source>The Journal of Biological Chemistry</source><volume>254</volume><fpage>4114</fpage><lpage>4118</lpage></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>AkhavanAghdam</surname> <given-names>Z</given-names></name><name><surname>Sinha</surname> <given-names>J</given-names></name><name><surname>Tabbaa</surname> <given-names>OP</given-names></name><name><surname>Hao</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dynamic control of gene regulatory logic by seemingly redundant transcription factors</article-title><source>eLife</source><volume>5</volume><elocation-id>e18458</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.18458</pub-id><pub-id pub-id-type="pmid">27690227</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arimoto</surname> <given-names>KI</given-names></name><name><surname>Löchte</surname> <given-names>S</given-names></name><name><surname>Stoner</surname> <given-names>SA</given-names></name><name><surname>Burkart</surname> <given-names>C</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Miyauchi</surname> <given-names>S</given-names></name><name><surname>Wilmes</surname> <given-names>S</given-names></name><name><surname>Fan</surname> <given-names>JB</given-names></name><name><surname>Heinisch</surname> <given-names>JJ</given-names></name><name><surname>Li</surname> <given-names>Z</given-names></name><name><surname>Yan</surname> <given-names>M</given-names></name><name><surname>Pellegrini</surname> <given-names>S</given-names></name><name><surname>Colland</surname> <given-names>F</given-names></name><name><surname>Piehler</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>24</volume><fpage>279</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1038/nsmb.3378</pub-id><pub-id pub-id-type="pmid">28165510</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashall</surname> <given-names>L</given-names></name><name><surname>Horton</surname> <given-names>CA</given-names></name><name><surname>Nelson</surname> <given-names>DE</given-names></name><name><surname>Paszek</surname> <given-names>P</given-names></name><name><surname>Harper</surname> <given-names>CV</given-names></name><name><surname>Sillitoe</surname> <given-names>K</given-names></name><name><surname>Ryan</surname> <given-names>S</given-names></name><name><surname>Spiller</surname> <given-names>DG</given-names></name><name><surname>Unitt</surname> <given-names>JF</given-names></name><name><surname>Broomhead</surname> <given-names>DS</given-names></name><name><surname>Kell</surname> <given-names>DB</given-names></name><name><surname>Rand</surname> <given-names>DA</given-names></name><name><surname>Sée</surname> <given-names>V</given-names></name><name><surname>White</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Pulsatile stimulation determines timing and specificity of NF-kappaB-dependent transcription</article-title><source>Science</source><volume>324</volume><fpage>242</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1126/science.1164860</pub-id><pub-id pub-id-type="pmid">19359585</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bajar</surname> <given-names>BT</given-names></name><name><surname>Lam</surname> <given-names>AJ</given-names></name><name><surname>Badiee</surname> <given-names>RK</given-names></name><name><surname>Oh</surname> <given-names>YH</given-names></name><name><surname>Chu</surname> <given-names>J</given-names></name><name><surname>Zhou</surname> <given-names>XX</given-names></name><name><surname>Kim</surname> <given-names>N</given-names></name><name><surname>Kim</surname> <given-names>BB</given-names></name><name><surname>Chung</surname> <given-names>M</given-names></name><name><surname>Yablonovitch</surname> <given-names>AL</given-names></name><name><surname>Cruz</surname> <given-names>BF</given-names></name><name><surname>Kulalert</surname> <given-names>K</given-names></name><name><surname>Tao</surname> <given-names>JJ</given-names></name><name><surname>Meyer</surname> <given-names>T</given-names></name><name><surname>Su</surname> <given-names>XD</given-names></name><name><surname>Lin</surname> <given-names>MZ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Fluorescent indicators for simultaneous reporting of all four cell cycle phases</article-title><source>Nature Methods</source><volume>13</volume><fpage>993</fpage><lpage>996</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4045</pub-id><pub-id pub-id-type="pmid">27798610</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barber</surname> <given-names>GN</given-names></name><name><surname>defense</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Viruses and apoptosis</article-title><source>Cell Death and Differentiation</source><volume>8</volume><fpage>113</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1146/annurev.micro.53.1.577</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batchelor</surname> <given-names>E</given-names></name><name><surname>Loewer</surname> <given-names>A</given-names></name><name><surname>Mock</surname> <given-names>C</given-names></name><name><surname>Lahav</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Stimulus-dependent dynamics of p53 in single cells</article-title><source>Molecular Systems Biology</source><volume>7</volume><elocation-id>488</elocation-id><pub-id pub-id-type="doi">10.1038/msb.2011.20</pub-id><pub-id pub-id-type="pmid">21556066</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behar</surname> <given-names>M</given-names></name><name><surname>Hoffmann</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Understanding the temporal codes of intra-cellular signals</article-title><source>Current Opinion in Genetics &amp; Development</source><volume>20</volume><fpage>684</fpage><lpage>693</lpage><pub-id pub-id-type="doi">10.1016/j.gde.2010.09.007</pub-id><pub-id pub-id-type="pmid">20956081</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beltra</surname> <given-names>J-C</given-names></name><name><surname>Decaluwe</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cytokines and persistent viral infections</article-title><source>Cytokine</source><volume>82</volume><fpage>4</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.cyto.2016.02.006</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco-Melo</surname> <given-names>D</given-names></name><name><surname>Nilsson-Payant</surname> <given-names>BE</given-names></name><name><surname>Liu</surname> <given-names>WC</given-names></name><name><surname>Uhl</surname> <given-names>S</given-names></name><name><surname>Hoagland</surname> <given-names>D</given-names></name><name><surname>Møller</surname> <given-names>R</given-names></name><name><surname>Jordan</surname> <given-names>TX</given-names></name><name><surname>Oishi</surname> <given-names>K</given-names></name><name><surname>Panis</surname> <given-names>M</given-names></name><name><surname>Sachs</surname> <given-names>D</given-names></name><name><surname>Wang</surname> <given-names>TT</given-names></name><name><surname>Schwartz</surname> <given-names>RE</given-names></name><name><surname>Lim</surname> <given-names>JK</given-names></name><name><surname>Albrecht</surname> <given-names>RA</given-names></name><name><surname>tenOever</surname> <given-names>BR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Imbalanced host response to SARS-CoV-2 drives development of COVID-19</article-title><source>Cell</source><volume>181</volume><fpage>1036</fpage><lpage>1045</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.04.026</pub-id><pub-id pub-id-type="pmid">32416070</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>SE</given-names></name><name><surname>Fraga</surname> <given-names>MF</given-names></name><name><surname>Weaver</surname> <given-names>IC</given-names></name><name><surname>Berdasco</surname> <given-names>M</given-names></name><name><surname>Szyf</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Variations in DNA methylation patterns during the cell cycle of HeLa cells</article-title><source>Epigenetics</source><volume>2</volume><fpage>54</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.4161/epi.2.1.3880</pub-id><pub-id pub-id-type="pmid">17965591</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cameron</surname> <given-names>MJ</given-names></name><name><surname>Bermejo-Martin</surname> <given-names>JF</given-names></name><name><surname>Danesh</surname> <given-names>A</given-names></name><name><surname>Muller</surname> <given-names>MP</given-names></name><name><surname>Kelvin</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Human immunopathogenesis of severe acute respiratory syndrome (SARS)</article-title><source>Virus Research</source><volume>133</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2007.02.014</pub-id><pub-id pub-id-type="pmid">17374415</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrero</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Confounding roles for type I interferons during bacterial and viral pathogenesis</article-title><source>International Immunology</source><volume>25</volume><fpage>663</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1093/intimm/dxt050</pub-id><pub-id pub-id-type="pmid">24158954</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheon</surname> <given-names>H</given-names></name><name><surname>Holvey-Bates</surname> <given-names>EG</given-names></name><name><surname>Schoggins</surname> <given-names>JW</given-names></name><name><surname>Forster</surname> <given-names>S</given-names></name><name><surname>Hertzog</surname> <given-names>P</given-names></name><name><surname>Imanaka</surname> <given-names>N</given-names></name><name><surname>Rice</surname> <given-names>CM</given-names></name><name><surname>Jackson</surname> <given-names>MW</given-names></name><name><surname>Junk</surname> <given-names>DJ</given-names></name><name><surname>Stark</surname> <given-names>GR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage</article-title><source>The EMBO Journal</source><volume>32</volume><fpage>2751</fpage><lpage>2763</lpage><pub-id pub-id-type="doi">10.1038/emboj.2013.203</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choubey</surname> <given-names>D</given-names></name><name><surname>Moudgil</surname> <given-names>KD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Interferons in autoimmune and inflammatory diseases: regulation and roles</article-title><source>Journal of Interferon &amp; Cytokine Research</source><volume>31</volume><fpage>857</fpage><lpage>865</lpage><pub-id pub-id-type="doi">10.1089/jir.2011.0101</pub-id><pub-id pub-id-type="pmid">22149411</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christman</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for Cancer therapy</article-title><source>Oncogene</source><volume>21</volume><fpage>5483</fpage><lpage>5495</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1205699</pub-id><pub-id pub-id-type="pmid">12154409</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Covert</surname> <given-names>MW</given-names></name><name><surname>Leung</surname> <given-names>TH</given-names></name><name><surname>Gaston</surname> <given-names>JE</given-names></name><name><surname>Baltimore</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Achieving stability of lipopolysaccharide-induced NF-kappaB activation</article-title><source>Science</source><volume>309</volume><fpage>1854</fpage><lpage>1857</lpage><pub-id pub-id-type="doi">10.1126/science.1112304</pub-id><pub-id pub-id-type="pmid">16166516</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crow</surname> <given-names>MK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Autoimmunity: interferon α or β: which is the culprit in autoimmune disease?</article-title><source>Nature Reviews Rheumatology</source><volume>12</volume><fpage>439</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1038/nrrheum.2016.117</pub-id><pub-id pub-id-type="pmid">27411904</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czerkies</surname> <given-names>M</given-names></name><name><surname>Korwek</surname> <given-names>Z</given-names></name><name><surname>Prus</surname> <given-names>W</given-names></name><name><surname>Kochańczyk</surname> <given-names>M</given-names></name><name><surname>Jaruszewicz-Błońska</surname> <given-names>J</given-names></name><name><surname>Tudelska</surname> <given-names>K</given-names></name><name><surname>Błoński</surname> <given-names>S</given-names></name><name><surname>Kimmel</surname> <given-names>M</given-names></name><name><surname>Brasier</surname> <given-names>AR</given-names></name><name><surname>Lipniacki</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cell fate in antiviral response arises in the crosstalk of IRF, NF-κB and JAK/STAT pathways</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>493</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-02640-8</pub-id><pub-id pub-id-type="pmid">29402958</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danino</surname> <given-names>T</given-names></name><name><surname>Mondragón-Palomino</surname> <given-names>O</given-names></name><name><surname>Tsimring</surname> <given-names>L</given-names></name><name><surname>Hasty</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A synchronized quorum of genetic clocks</article-title><source>Nature</source><volume>463</volume><fpage>326</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1038/nature08753</pub-id><pub-id pub-id-type="pmid">20090747</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desjobert</surname> <given-names>C</given-names></name><name><surname>El Maï</surname> <given-names>M</given-names></name><name><surname>Gérard-Hirne</surname> <given-names>T</given-names></name><name><surname>Guianvarc'h</surname> <given-names>D</given-names></name><name><surname>Carrier</surname> <given-names>A</given-names></name><name><surname>Pottier</surname> <given-names>C</given-names></name><name><surname>Arimondo</surname> <given-names>PB</given-names></name><name><surname>Riond</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Combined analysis of DNA methylation and cell cycle in Cancer cells</article-title><source>Epigenetics</source><volume>10</volume><fpage>82</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1080/15592294.2014.995542</pub-id><pub-id pub-id-type="pmid">25531272</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doherty</surname> <given-names>MR</given-names></name><name><surname>Cheon</surname> <given-names>H</given-names></name><name><surname>Junk</surname> <given-names>DJ</given-names></name><name><surname>Vinayak</surname> <given-names>S</given-names></name><name><surname>Varadan</surname> <given-names>V</given-names></name><name><surname>Telli</surname> <given-names>ML</given-names></name><name><surname>Ford</surname> <given-names>JM</given-names></name><name><surname>Stark</surname> <given-names>GR</given-names></name><name><surname>Jackson</surname> <given-names>MW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Interferon-beta represses Cancer stem cell properties in triple-negative breast Cancer</article-title><source>PNAS</source><volume>114</volume><fpage>13792</fpage><lpage>13797</lpage><pub-id pub-id-type="doi">10.1073/pnas.1713728114</pub-id><pub-id pub-id-type="pmid">29229854</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>François-Newton</surname> <given-names>V</given-names></name><name><surname>Magno de Freitas Almeida</surname> <given-names>G</given-names></name><name><surname>Payelle-Brogard</surname> <given-names>B</given-names></name><name><surname>Monneron</surname> <given-names>D</given-names></name><name><surname>Pichard-Garcia</surname> <given-names>L</given-names></name><name><surname>Piehler</surname> <given-names>J</given-names></name><name><surname>Pellegrini</surname> <given-names>S</given-names></name><name><surname>Uzé</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon α response</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e22200</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0022200</pub-id><pub-id pub-id-type="pmid">21779393</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname> <given-names>T</given-names></name><name><surname>Tuppi</surname> <given-names>M</given-names></name><name><surname>Hugle</surname> <given-names>M</given-names></name><name><surname>Dötsch</surname> <given-names>V</given-names></name><name><surname>van Wijk</surname> <given-names>SJL</given-names></name><name><surname>Fulda</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cell cycle arrest in mitosis promotes interferon-induced necroptosis</article-title><source>Cell Death &amp; Differentiation</source><volume>26</volume><fpage>2046</fpage><lpage>2060</lpage><pub-id pub-id-type="doi">10.1038/s41418-019-0298-5</pub-id><pub-id pub-id-type="pmid">30742091</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname> <given-names>AS</given-names></name><name><surname>O'Shea</surname> <given-names>EK</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Promoter decoding of transcription factor dynamics involves a trade-off between noise and control of gene expression</article-title><source>Molecular Systems Biology</source><volume>9</volume><elocation-id>704</elocation-id><pub-id pub-id-type="doi">10.1038/msb.2013.56</pub-id><pub-id pub-id-type="pmid">24189399</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname> <given-names>AS</given-names></name><name><surname>O'Shea</surname> <given-names>EK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cis determinants of promoter threshold and activation timescale</article-title><source>Cell Reports</source><volume>12</volume><fpage>1226</fpage><lpage>1233</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.07.035</pub-id><pub-id pub-id-type="pmid">26279577</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname> <given-names>N</given-names></name><name><surname>Budnik</surname> <given-names>BA</given-names></name><name><surname>Gunawardena</surname> <given-names>J</given-names></name><name><surname>O'Shea</surname> <given-names>EK</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Tunable signal processing through modular control of transcription factor translocation</article-title><source>Science</source><volume>339</volume><fpage>460</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1126/science.1227299</pub-id><pub-id pub-id-type="pmid">23349292</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname> <given-names>N</given-names></name><name><surname>O'Shea</surname> <given-names>EK</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Signal-dependent dynamics of transcription factor translocation controls gene expression</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>19</volume><fpage>31</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1038/nsmb.2192</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harton</surname> <given-names>MD</given-names></name><name><surname>Koh</surname> <given-names>WS</given-names></name><name><surname>Bunker</surname> <given-names>AD</given-names></name><name><surname>Singh</surname> <given-names>A</given-names></name><name><surname>Batchelor</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>p53 pulse modulation differentially regulates target gene promoters to regulate cell fate decisions</article-title><source>Molecular Systems Biology</source><volume>15</volume><elocation-id>e8685</elocation-id><pub-id pub-id-type="doi">10.15252/msb.20188685</pub-id><pub-id pub-id-type="pmid">31556489</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hersen</surname> <given-names>P</given-names></name><name><surname>McClean</surname> <given-names>MN</given-names></name><name><surname>Mahadevan</surname> <given-names>L</given-names></name><name><surname>Ramanathan</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Signal processing by the HOG MAP kinase pathway</article-title><source>PNAS</source><volume>105</volume><fpage>7165</fpage><lpage>7170</lpage><pub-id pub-id-type="doi">10.1073/pnas.0710770105</pub-id><pub-id pub-id-type="pmid">18480263</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname> <given-names>A</given-names></name><name><surname>Levchenko</surname> <given-names>A</given-names></name><name><surname>Scott</surname> <given-names>ML</given-names></name><name><surname>Baltimore</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation</article-title><source>Science</source><volume>298</volume><fpage>1241</fpage><lpage>1245</lpage><pub-id pub-id-type="doi">10.1126/science.1071914</pub-id><pub-id pub-id-type="pmid">12424381</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname> <given-names>CH</given-names></name><name><surname>Altschuler</surname> <given-names>SJ</given-names></name><name><surname>Wu</surname> <given-names>LF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Patterns of early p21 dynamics determine Proliferation-Senescence cell fate after chemotherapy</article-title><source>Cell</source><volume>178</volume><fpage>361</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.05.041</pub-id><pub-id pub-id-type="pmid">31204100</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javanmoghadam-Kamrani</surname> <given-names>S</given-names></name><name><surname>Keyomarsi</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Synchronization of the cell cycle using lovastatin</article-title><source>Cell Cycle</source><volume>7</volume><fpage>2434</fpage><lpage>2440</lpage><pub-id pub-id-type="doi">10.4161/cc.6364</pub-id><pub-id pub-id-type="pmid">18677105</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeknić</surname> <given-names>S</given-names></name><name><surname>Kudo</surname> <given-names>T</given-names></name><name><surname>Covert</surname> <given-names>MW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Techniques for studying decoding of single cell dynamics</article-title><source>Frontiers in Immunology</source><volume>10</volume><elocation-id>755</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.00755</pub-id><pub-id pub-id-type="pmid">31031756</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>Y</given-names></name><name><surname>AkhavanAghdam</surname> <given-names>Z</given-names></name><name><surname>Tsimring</surname> <given-names>LS</given-names></name><name><surname>Hao</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Coupled feedback loops control the stimulus-dependent dynamics of the yeast transcription factor Msn2</article-title><source>Journal of Biological Chemistry</source><volume>292</volume><fpage>12366</fpage><lpage>12372</lpage><pub-id pub-id-type="doi">10.1074/jbc.C117.800896</pub-id><pub-id pub-id-type="pmid">28637875</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>2020_Sorn_Elife</data-title><source>GitHub</source><version designator="08864ed">08864ed</version><ext-link ext-link-type="uri" xlink:href="https://github.com/yaj030/2020_Sorn_Elife">https://github.com/yaj030/2020_Sorn_Elife</ext-link></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamada</surname> <given-names>R</given-names></name><name><surname>Yang</surname> <given-names>W</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Patel</surname> <given-names>MC</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Ouda</surname> <given-names>R</given-names></name><name><surname>Dey</surname> <given-names>A</given-names></name><name><surname>Wakabayashi</surname> <given-names>Y</given-names></name><name><surname>Sakaguchi</surname> <given-names>K</given-names></name><name><surname>Fujita</surname> <given-names>T</given-names></name><name><surname>Tamura</surname> <given-names>T</given-names></name><name><surname>Zhu</surname> <given-names>J</given-names></name><name><surname>Ozato</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Interferon stimulation creates chromatin marks and establishes transcriptional memory</article-title><source>PNAS</source><volume>115</volume><fpage>E9162</fpage><lpage>E9171</lpage><pub-id pub-id-type="doi">10.1073/pnas.1720930115</pub-id><pub-id pub-id-type="pmid">30201712</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keyomarsi</surname> <given-names>K</given-names></name><name><surname>Sandoval</surname> <given-names>L</given-names></name><name><surname>Band</surname> <given-names>V</given-names></name><name><surname>Pardee</surname> <given-names>AB</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin</article-title><source>Cancer Research</source><volume>51</volume><fpage>3602</fpage><lpage>3609</lpage><pub-id pub-id-type="pmid">1711413</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Killip</surname> <given-names>MJ</given-names></name><name><surname>Smith</surname> <given-names>M</given-names></name><name><surname>Jackson</surname> <given-names>D</given-names></name><name><surname>Randall</surname> <given-names>RE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Activation of the interferon induction cascade by influenza a viruses requires viral RNA synthesis and nuclear export</article-title><source>Journal of Virology</source><volume>88</volume><fpage>3942</fpage><lpage>3952</lpage><pub-id pub-id-type="doi">10.1128/JVI.03109-13</pub-id><pub-id pub-id-type="pmid">24478437</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>JH</given-names></name><name><surname>Luo</surname> <given-names>JK</given-names></name><name><surname>Zhang</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The level of hepatitis B virus replication is not affected by protein ISG15 modification but is reduced by inhibition of UBP43 (USP18) expression</article-title><source>The Journal of Immunology</source><volume>181</volume><fpage>6467</fpage><lpage>6472</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.181.9.6467</pub-id><pub-id pub-id-type="pmid">18941237</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolnik</surname> <given-names>M</given-names></name><name><surname>Tsimring</surname> <given-names>LS</given-names></name><name><surname>Hasty</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Vacuum-assisted cell loading enables shear-free mammalian microfluidic culture</article-title><source>Lab on a Chip</source><volume>12</volume><fpage>4732</fpage><lpage>4737</lpage><pub-id pub-id-type="doi">10.1039/c2lc40569e</pub-id><pub-id pub-id-type="pmid">22961584</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolodziej</surname> <given-names>M</given-names></name><name><surname>Goetz</surname> <given-names>C</given-names></name><name><surname>Di Fazio</surname> <given-names>P</given-names></name><name><surname>Montalbano</surname> <given-names>R</given-names></name><name><surname>Ocker</surname> <given-names>M</given-names></name><name><surname>Strik</surname> <given-names>H</given-names></name><name><surname>Quint</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Roscovitine has anti-proliferative and pro-apoptotic effects on glioblastoma cell lines: a pilot study</article-title><source>Oncology Reports</source><volume>34</volume><fpage>1549</fpage><lpage>1556</lpage><pub-id pub-id-type="doi">10.3892/or.2015.4105</pub-id><pub-id pub-id-type="pmid">26151768</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komaki</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>iMETHYL: an integrative database of human DNA methylation <italic>gene expression</italic> and genomic variation</article-title><source>Nature</source><volume>5</volume><elocation-id>18008</elocation-id><pub-id pub-id-type="doi">10.1038/hgv.2018.8</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuri</surname> <given-names>T</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Habjan</surname> <given-names>M</given-names></name><name><surname>Martínez-Sobrido</surname> <given-names>L</given-names></name><name><surname>García-Sastre</surname> <given-names>A</given-names></name><name><surname>Yuan</surname> <given-names>Z</given-names></name><name><surname>Weber</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation</article-title><source>Journal of General Virology</source><volume>90</volume><fpage>2686</fpage><lpage>2694</lpage><pub-id pub-id-type="doi">10.1099/vir.0.013599-0</pub-id><pub-id pub-id-type="pmid">19625461</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landskron</surname> <given-names>G</given-names></name><name><surname>De la Fuente</surname> <given-names>M</given-names></name><name><surname>Thuwajit</surname> <given-names>P</given-names></name><name><surname>Thuwajit</surname> <given-names>C</given-names></name><name><surname>Hermoso</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Chronic inflammation and cytokines in the tumor microenvironment</article-title><source>Journal of Immunology Research</source><volume>2014</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1155/2014/149185</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langan</surname> <given-names>TJ</given-names></name><name><surname>Chou</surname> <given-names>RC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Synchronization of mammalian cell cultures by serum deprivation</article-title><source>Methods in Molecular Biology</source><volume>761</volume><fpage>75</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1007/978-1-61779-182-6_5</pub-id><pub-id pub-id-type="pmid">21755442</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavelle</surname> <given-names>D</given-names></name><name><surname>DeSimone</surname> <given-names>J</given-names></name><name><surname>Hankewych</surname> <given-names>M</given-names></name><name><surname>Kousnetzova</surname> <given-names>T</given-names></name><name><surname>Chen</surname> <given-names>YH</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Decitabine induces cell cycle arrest at the G1 phase via p21(WAF1) and the G2/M phase via the p38 MAP kinase pathway</article-title><source>Leukemia Research</source><volume>27</volume><fpage>999</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1016/S0145-2126(03)00068-7</pub-id><pub-id pub-id-type="pmid">12859993</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemmon</surname> <given-names>MA</given-names></name><name><surname>Freed</surname> <given-names>DM</given-names></name><name><surname>Schlessinger</surname> <given-names>J</given-names></name><name><surname>Kiyatkin</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The dark side of cell signaling: positive roles for negative regulators</article-title><source>Cell</source><volume>164</volume><fpage>1172</fpage><lpage>1184</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.02.047</pub-id><pub-id pub-id-type="pmid">26967284</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Roberts</surname> <given-names>J</given-names></name><name><surname>AkhavanAghdam</surname> <given-names>Z</given-names></name><name><surname>Hao</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017a</year><article-title>Mitogen-activated protein kinase (MAPK) dynamics determine cell fate in the yeast mating response</article-title><source>Journal of Biological Chemistry</source><volume>292</volume><fpage>20354</fpage><lpage>20361</lpage><pub-id pub-id-type="doi">10.1074/jbc.AC117.000548</pub-id><pub-id pub-id-type="pmid">29123025</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Jin</surname> <given-names>M</given-names></name><name><surname>O'Laughlin</surname> <given-names>R</given-names></name><name><surname>Bittihn</surname> <given-names>P</given-names></name><name><surname>Tsimring</surname> <given-names>LS</given-names></name><name><surname>Pillus</surname> <given-names>L</given-names></name><name><surname>Hasty</surname> <given-names>J</given-names></name><name><surname>Hao</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017b</year><article-title>Multigenerational silencing dynamics control cell aging</article-title><source>PNAS</source><volume>114</volume><fpage>11253</fpage><lpage>11258</lpage><pub-id pub-id-type="doi">10.1073/pnas.1703379114</pub-id><pub-id pub-id-type="pmid">29073021</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liau</surname> <given-names>NPD</given-names></name><name><surname>Laktyushin</surname> <given-names>A</given-names></name><name><surname>Lucet</surname> <given-names>IS</given-names></name><name><surname>Murphy</surname> <given-names>JM</given-names></name><name><surname>Yao</surname> <given-names>S</given-names></name><name><surname>Whitlock</surname> <given-names>E</given-names></name><name><surname>Callaghan</surname> <given-names>K</given-names></name><name><surname>Nicola</surname> <given-names>NA</given-names></name><name><surname>Kershaw</surname> <given-names>NJ</given-names></name><name><surname>Babon</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The molecular basis of JAK/STAT inhibition by SOCS1</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>1558</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-04013-1</pub-id><pub-id pub-id-type="pmid">29674694</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Chen</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Soares</surname> <given-names>F</given-names></name><name><surname>Fischer</surname> <given-names>M</given-names></name><name><surname>Meng</surname> <given-names>F</given-names></name><name><surname>Du</surname> <given-names>Z</given-names></name><name><surname>Lin</surname> <given-names>C</given-names></name><name><surname>Meyer</surname> <given-names>C</given-names></name><name><surname>DeCaprio</surname> <given-names>JA</given-names></name><name><surname>Brown</surname> <given-names>M</given-names></name><name><surname>Liu</surname> <given-names>XS</given-names></name><name><surname>He</surname> <given-names>HH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Transcriptional landscape of the human cell cycle</article-title><source>PNAS</source><volume>114</volume><fpage>3473</fpage><lpage>3478</lpage><pub-id pub-id-type="doi">10.1073/pnas.1617636114</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Lokugamage</surname> <given-names>KH</given-names></name><name><surname>Schindewolf</surname> <given-names>A</given-names></name><name><surname>Rajsbaum</surname> <given-names>C</given-names></name><name><surname>Menachery</surname> <given-names>VD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SARS-CoV-2 is sensitive to type I interferon pretreatment</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.03.07.982264</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makowska</surname> <given-names>Z</given-names></name><name><surname>Duong</surname> <given-names>FHT</given-names></name><name><surname>Trincucci</surname> <given-names>G</given-names></name><name><surname>Tough</surname> <given-names>DF</given-names></name><name><surname>Heim</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Interferon-β and interferon-λ signaling is not affected by interferon-induced refractoriness to interferon-α in vivo</article-title><source>Hepatology</source><volume>53</volume><fpage>1171</fpage><lpage>1180</lpage><pub-id pub-id-type="doi">10.1002/hep.24189</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malakhova</surname> <given-names>OA</given-names></name><name><surname>Yan</surname> <given-names>M</given-names></name><name><surname>Malakhov</surname> <given-names>MP</given-names></name><name><surname>Yuan</surname> <given-names>Y</given-names></name><name><surname>Ritchie</surname> <given-names>KJ</given-names></name><name><surname>Kim</surname> <given-names>KI</given-names></name><name><surname>Peterson</surname> <given-names>LF</given-names></name><name><surname>Shuai</surname> <given-names>K</given-names></name><name><surname>Zhang</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Protein ISGylation modulates the JAK-STAT signaling pathway</article-title><source>Genes &amp; Development</source><volume>17</volume><fpage>455</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1101/gad.1056303</pub-id><pub-id pub-id-type="pmid">12600939</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malakhova</surname> <given-names>OA</given-names></name><name><surname>Kim</surname> <given-names>KII</given-names></name><name><surname>Luo</surname> <given-names>J-K</given-names></name><name><surname>Zou</surname> <given-names>W</given-names></name><name><surname>Kumar</surname> <given-names>KGS</given-names></name><name><surname>Fuchs</surname> <given-names>SY</given-names></name><name><surname>Shuai</surname> <given-names>K</given-names></name><name><surname>Zhang</surname> <given-names>D-E</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity</article-title><source>The EMBO Journal</source><volume>25</volume><fpage>2358</fpage><lpage>2367</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601149</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangan</surname> <given-names>S</given-names></name><name><surname>Zaslaver</surname> <given-names>A</given-names></name><name><surname>Alon</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The coherent feedforward loop serves as a sign-sensitive delay element in transcription networks</article-title><source>Journal of Molecular Biology</source><volume>334</volume><fpage>197</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2003.09.049</pub-id><pub-id pub-id-type="pmid">14607112</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNab</surname> <given-names>F</given-names></name><name><surname>Mayer-Barber</surname> <given-names>K</given-names></name><name><surname>Sher</surname> <given-names>A</given-names></name><name><surname>Wack</surname> <given-names>A</given-names></name><name><surname>O'Garra</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Type I interferons in infectious disease</article-title><source>Nature Reviews Immunology</source><volume>15</volume><fpage>87</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1038/nri3787</pub-id><pub-id pub-id-type="pmid">25614319</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medrano</surname> <given-names>RFV</given-names></name><name><surname>Hunger</surname> <given-names>A</given-names></name><name><surname>Mendonça</surname> <given-names>SA</given-names></name><name><surname>Barbuto</surname> <given-names>JAM</given-names></name><name><surname>Strauss</surname> <given-names>BE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Immunomodulatory and antitumor effects of type I interferons and their application in Cancer therapy</article-title><source>Oncotarget</source><volume>8</volume><fpage>71249</fpage><lpage>71284</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.19531</pub-id><pub-id pub-id-type="pmid">29050360</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mettetal</surname> <given-names>JT</given-names></name><name><surname>Muzzey</surname> <given-names>D</given-names></name><name><surname>Gómez-Uribe</surname> <given-names>C</given-names></name><name><surname>van Oudenaarden</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The frequency dependence of osmo-adaptation in <italic>Saccharomyces cerevisiae</italic></article-title><source>Science</source><volume>319</volume><fpage>482</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1126/science.1151582</pub-id><pub-id pub-id-type="pmid">18218902</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname> <given-names>H</given-names></name><name><surname>Hollenbaugh</surname> <given-names>JA</given-names></name><name><surname>Zand</surname> <given-names>MS</given-names></name><name><surname>Holden-Wiltse</surname> <given-names>J</given-names></name><name><surname>Mosmann</surname> <given-names>TR</given-names></name><name><surname>Perelson</surname> <given-names>AS</given-names></name><name><surname>Wu</surname> <given-names>H</given-names></name><name><surname>Topham</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus</article-title><source>Journal of Virology</source><volume>84</volume><fpage>6687</fpage><lpage>6698</lpage><pub-id pub-id-type="doi">10.1128/JVI.00266-10</pub-id><pub-id pub-id-type="pmid">20410284</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Min</surname> <given-names>M</given-names></name><name><surname>Rong</surname> <given-names>Y</given-names></name><name><surname>Tian</surname> <given-names>C</given-names></name><name><surname>Spencer</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Temporal integration of mitogen history in mother cells controls proliferation of daughter cells</article-title><source>Science</source><volume>368</volume><fpage>1261</fpage><lpage>1265</lpage><pub-id pub-id-type="doi">10.1126/science.aay8241</pub-id><pub-id pub-id-type="pmid">32241885</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname> <given-names>A</given-names></name><name><surname>Wei</surname> <given-names>P</given-names></name><name><surname>Lim</surname> <given-names>WA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Oscillatory stress stimulation uncovers an achilles' heel of the yeast MAPK signaling network</article-title><source>Science</source><volume>350</volume><fpage>1379</fpage><lpage>1383</lpage><pub-id pub-id-type="doi">10.1126/science.aab0892</pub-id><pub-id pub-id-type="pmid">26586187</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Momparler</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Epigenetic therapy of Cancer with 5-aza-2'-deoxycytidine (decitabine)</article-title><source>Seminars in Oncology</source><volume>32</volume><fpage>443</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1053/j.seminoncol.2005.07.008</pub-id><pub-id pub-id-type="pmid">16210084</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mönke</surname> <given-names>G</given-names></name><name><surname>Cristiano</surname> <given-names>E</given-names></name><name><surname>Finzel</surname> <given-names>A</given-names></name><name><surname>Friedrich</surname> <given-names>D</given-names></name><name><surname>Herzel</surname> <given-names>H</given-names></name><name><surname>Falcke</surname> <given-names>M</given-names></name><name><surname>Loewer</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Excitability in the p53 network mediates robust signaling with tunable activation thresholds in single cells</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>46571</elocation-id><pub-id pub-id-type="doi">10.1038/srep46571</pub-id><pub-id pub-id-type="pmid">28417973</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname> <given-names>DE</given-names></name><name><surname>Ihekwaba</surname> <given-names>AE</given-names></name><name><surname>Elliott</surname> <given-names>M</given-names></name><name><surname>Johnson</surname> <given-names>JR</given-names></name><name><surname>Gibney</surname> <given-names>CA</given-names></name><name><surname>Foreman</surname> <given-names>BE</given-names></name><name><surname>Nelson</surname> <given-names>G</given-names></name><name><surname>See</surname> <given-names>V</given-names></name><name><surname>Horton</surname> <given-names>CA</given-names></name><name><surname>Spiller</surname> <given-names>DG</given-names></name><name><surname>Edwards</surname> <given-names>SW</given-names></name><name><surname>McDowell</surname> <given-names>HP</given-names></name><name><surname>Unitt</surname> <given-names>JF</given-names></name><name><surname>Sullivan</surname> <given-names>E</given-names></name><name><surname>Grimley</surname> <given-names>R</given-names></name><name><surname>Benson</surname> <given-names>N</given-names></name><name><surname>Broomhead</surname> <given-names>D</given-names></name><name><surname>Kell</surname> <given-names>DB</given-names></name><name><surname>White</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Oscillations in NF-kappaB signaling control the dynamics of gene expression</article-title><source>Science</source><volume>306</volume><fpage>704</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1126/science.1099962</pub-id><pub-id pub-id-type="pmid">15499023</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogrodnik</surname> <given-names>M</given-names></name><name><surname>Salmonowicz</surname> <given-names>H</given-names></name><name><surname>Brown</surname> <given-names>R</given-names></name><name><surname>Turkowska</surname> <given-names>J</given-names></name><name><surname>Średniawa</surname> <given-names>W</given-names></name><name><surname>Pattabiraman</surname> <given-names>S</given-names></name><name><surname>Amen</surname> <given-names>T</given-names></name><name><surname>Abraham</surname> <given-names>AC</given-names></name><name><surname>Eichler</surname> <given-names>N</given-names></name><name><surname>Lyakhovetsky</surname> <given-names>R</given-names></name><name><surname>Kaganovich</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Dynamic JUNQ inclusion bodies are asymmetrically inherited in mammalian cell lines through the asymmetric partitioning of vimentin</article-title><source>PNAS</source><volume>111</volume><fpage>8049</fpage><lpage>8054</lpage><pub-id pub-id-type="doi">10.1073/pnas.1324035111</pub-id><pub-id pub-id-type="pmid">24843142</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ori</surname> <given-names>H</given-names></name><name><surname>Marder</surname> <given-names>E</given-names></name><name><surname>Marom</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cellular function given parametric variation in the Hodgkin and huxley model of excitability</article-title><source>PNAS</source><volume>115</volume><fpage>E8211</fpage><lpage>E8218</lpage><pub-id pub-id-type="doi">10.1073/pnas.1808552115</pub-id><pub-id pub-id-type="pmid">30111538</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paek</surname> <given-names>AL</given-names></name><name><surname>Liu</surname> <given-names>JC</given-names></name><name><surname>Loewer</surname> <given-names>A</given-names></name><name><surname>Forrester</surname> <given-names>WC</given-names></name><name><surname>Lahav</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cell-to-Cell variation in p53 dynamics leads to fractional killing</article-title><source>Cell</source><volume>165</volume><fpage>631</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.03.025</pub-id><pub-id pub-id-type="pmid">27062928</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patil</surname> <given-names>S</given-names></name><name><surname>Fribourg</surname> <given-names>M</given-names></name><name><surname>Ge</surname> <given-names>Y</given-names></name><name><surname>Batish</surname> <given-names>M</given-names></name><name><surname>Tyagi</surname> <given-names>S</given-names></name><name><surname>Hayot</surname> <given-names>F</given-names></name><name><surname>Sealfon</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Single-cell analysis shows that paracrine signaling by first responder cells shapes the interferon-β response to viral infection</article-title><source>Science Signaling</source><volume>8</volume><elocation-id>ra16</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.2005728</pub-id><pub-id pub-id-type="pmid">25670204</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname> <given-names>AK</given-names></name><name><surname>Chen</surname> <given-names>G</given-names></name><name><surname>Zheng</surname> <given-names>D</given-names></name><name><surname>Tang</surname> <given-names>H</given-names></name><name><surname>Cheng</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The host type I interferon response to viral and bacterial infections</article-title><source>Cell Research</source><volume>15</volume><fpage>407</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1038/sj.cr.7290309</pub-id><pub-id pub-id-type="pmid">15987599</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phipps-Yonas</surname> <given-names>H</given-names></name><name><surname>Seto</surname> <given-names>J</given-names></name><name><surname>Sealfon</surname> <given-names>SC</given-names></name><name><surname>Moran</surname> <given-names>TM</given-names></name><name><surname>Fernandez-Sesma</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus</article-title><source>PLOS Pathogens</source><volume>4</volume><elocation-id>e1000193</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000193</pub-id><pub-id pub-id-type="pmid">18974865</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Platanias</surname> <given-names>LC</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Mechanisms of type-I- and type-II-interferon-mediated signalling</article-title><source>Nature Reviews Immunology</source><volume>5</volume><fpage>375</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1038/nri1604</pub-id><pub-id pub-id-type="pmid">15864272</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purvis</surname> <given-names>JE</given-names></name><name><surname>Karhohs</surname> <given-names>KW</given-names></name><name><surname>Mock</surname> <given-names>C</given-names></name><name><surname>Batchelor</surname> <given-names>E</given-names></name><name><surname>Loewer</surname> <given-names>A</given-names></name><name><surname>Lahav</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>p53 dynamics control cell fate</article-title><source>Science</source><volume>336</volume><fpage>1440</fpage><lpage>1444</lpage><pub-id pub-id-type="doi">10.1126/science.1218351</pub-id><pub-id pub-id-type="pmid">22700930</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purvis</surname> <given-names>JE</given-names></name><name><surname>Lahav</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Encoding and decoding cellular information through signaling dynamics</article-title><source>Cell</source><volume>152</volume><fpage>945</fpage><lpage>956</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.02.005</pub-id><pub-id pub-id-type="pmid">23452846</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ran</surname> <given-names>FA</given-names></name><name><surname>Hsu</surname> <given-names>PD</given-names></name><name><surname>Wright</surname> <given-names>J</given-names></name><name><surname>Agarwala</surname> <given-names>V</given-names></name><name><surname>Scott</surname> <given-names>DA</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genome engineering using the CRISPR-Cas9 system</article-title><source>Nature Protocols</source><volume>8</volume><fpage>2281</fpage><lpage>2308</lpage><pub-id pub-id-type="doi">10.1038/nprot.2013.143</pub-id><pub-id pub-id-type="pmid">24157548</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rand</surname> <given-names>U</given-names></name><name><surname>Rinas</surname> <given-names>M</given-names></name><name><surname>Schwerk</surname> <given-names>J</given-names></name><name><surname>Nöhren</surname> <given-names>G</given-names></name><name><surname>Linnes</surname> <given-names>M</given-names></name><name><surname>Kröger</surname> <given-names>A</given-names></name><name><surname>Flossdorf</surname> <given-names>M</given-names></name><name><surname>Kály-Kullai</surname> <given-names>K</given-names></name><name><surname>Hauser</surname> <given-names>H</given-names></name><name><surname>Höfer</surname> <given-names>T</given-names></name><name><surname>Köster</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Multi-layered stochasticity and paracrine signal propagation shape the type-I interferon response</article-title><source>Molecular Systems Biology</source><volume>8</volume><elocation-id>584</elocation-id><pub-id pub-id-type="doi">10.1038/msb.2012.17</pub-id><pub-id pub-id-type="pmid">22617958</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reyes</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>JY</given-names></name><name><surname>Stewart-Ornstein</surname> <given-names>J</given-names></name><name><surname>Karhohs</surname> <given-names>KW</given-names></name><name><surname>Mock</surname> <given-names>CS</given-names></name><name><surname>Lahav</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Fluctuations in p53 signaling allow escape from Cell-Cycle arrest</article-title><source>Molecular Cell</source><volume>71</volume><fpage>581</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2018.06.031</pub-id><pub-id pub-id-type="pmid">30057196</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname> <given-names>KJ</given-names></name><name><surname>Hahn</surname> <given-names>CS</given-names></name><name><surname>Kim</surname> <given-names>KI</given-names></name><name><surname>Yan</surname> <given-names>M</given-names></name><name><surname>Rosario</surname> <given-names>D</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>de la Torre</surname> <given-names>JC</given-names></name><name><surname>Zhang</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection</article-title><source>Nature Medicine</source><volume>10</volume><fpage>1374</fpage><lpage>1378</lpage><pub-id pub-id-type="doi">10.1038/nm1133</pub-id><pub-id pub-id-type="pmid">15531891</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Pla</surname> <given-names>A</given-names></name><name><surname>Patel</surname> <given-names>P</given-names></name><name><surname>Maecker</surname> <given-names>HT</given-names></name><name><surname>Rossello-Urgell</surname> <given-names>J</given-names></name><name><surname>Baldwin</surname> <given-names>N</given-names></name><name><surname>Bennett</surname> <given-names>L</given-names></name><name><surname>Cantrell</surname> <given-names>V</given-names></name><name><surname>Baisch</surname> <given-names>J</given-names></name><name><surname>Punaro</surname> <given-names>M</given-names></name><name><surname>Gotte</surname> <given-names>A</given-names></name><name><surname>Nassi</surname> <given-names>L</given-names></name><name><surname>Wright</surname> <given-names>T</given-names></name><name><surname>Palucka</surname> <given-names>AK</given-names></name><name><surname>Banchereau</surname> <given-names>J</given-names></name><name><surname>Pascual</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>IFN priming is necessary but not sufficient to turn on a migratory dendritic cell program in lupus monocytes</article-title><source>The Journal of Immunology</source><volume>192</volume><fpage>5586</fpage><lpage>5598</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1301319</pub-id><pub-id pub-id-type="pmid">24829414</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sallard</surname> <given-names>E</given-names></name><name><surname>Lescure</surname> <given-names>F-X</given-names></name><name><surname>Yazdanpanah</surname> <given-names>Y</given-names></name><name><surname>Mentre</surname> <given-names>F</given-names></name><name><surname>Peiffer-Smadja</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Type 1 interferons as a potential treatment against COVID-19</article-title><source>Antiviral Research</source><volume>178</volume><elocation-id>104791</elocation-id><pub-id pub-id-type="doi">10.1016/j.antiviral.2020.104791</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarasin-Filipowicz</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Yan</surname> <given-names>M</given-names></name><name><surname>Duong</surname> <given-names>FH</given-names></name><name><surname>Poli</surname> <given-names>V</given-names></name><name><surname>Hilton</surname> <given-names>DJ</given-names></name><name><surname>Zhang</surname> <given-names>DE</given-names></name><name><surname>Heim</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43</article-title><source>Molecular and Cellular Biology</source><volume>29</volume><fpage>4841</fpage><lpage>4851</lpage><pub-id pub-id-type="doi">10.1128/MCB.00224-09</pub-id><pub-id pub-id-type="pmid">19564419</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scagnolari</surname> <given-names>C</given-names></name><name><surname>Antonelli</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Type I interferon and HIV: subtle balance between antiviral activity, immunopathogenesis and the microbiome</article-title><source>Cytokine &amp; Growth Factor Reviews</source><volume>40</volume><fpage>19</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.cytogfr.2018.03.003</pub-id><pub-id pub-id-type="pmid">29576284</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname> <given-names>WM</given-names></name><name><surname>Chevillotte</surname> <given-names>MD</given-names></name><name><surname>Rice</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Interferon-stimulated genes: a complex web of host defenses</article-title><source>Annual Review of Immunology</source><volume>32</volume><fpage>513</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120231</pub-id><pub-id pub-id-type="pmid">24555472</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoggins</surname> <given-names>JW</given-names></name><name><surname>Rice</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Interferon-stimulated genes and their antiviral effector functions</article-title><source>Current Opinion in Virology</source><volume>1</volume><fpage>519</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1016/j.coviro.2011.10.008</pub-id><pub-id pub-id-type="pmid">22328912</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The molecular basis for differential type I interferon signaling</article-title><source>Journal of Biological Chemistry</source><volume>292</volume><fpage>7285</fpage><lpage>7294</lpage><pub-id pub-id-type="doi">10.1074/jbc.R116.774562</pub-id><pub-id pub-id-type="pmid">28289098</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname> <given-names>S</given-names></name><name><surname>Cheng</surname> <given-names>Z</given-names></name><name><surname>Sheu</surname> <given-names>KM</given-names></name><name><surname>Chen</surname> <given-names>YH</given-names></name><name><surname>Hoffmann</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Gene regulatory strategies that decode the duration of nfκb dynamics contribute to LPS- versus TNF-Specific gene expression</article-title><source>Cell Systems</source><volume>10</volume><fpage>169</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2019.12.004</pub-id><pub-id pub-id-type="pmid">31972132</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen-Orr</surname> <given-names>SS</given-names></name><name><surname>Milo</surname> <given-names>R</given-names></name><name><surname>Mangan</surname> <given-names>S</given-names></name><name><surname>Alon</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Network motifs in the transcriptional regulation network of <italic>Escherichia coli</italic></article-title><source>Nature Genetics</source><volume>31</volume><fpage>64</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1038/ng881</pub-id><pub-id pub-id-type="pmid">11967538</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname> <given-names>DY</given-names></name><name><surname>Sung Kang</surname> <given-names>H</given-names></name><name><surname>Kim</surname> <given-names>GY</given-names></name><name><surname>Kim</surname> <given-names>WJ</given-names></name><name><surname>Yoo</surname> <given-names>YH</given-names></name><name><surname>Choi</surname> <given-names>YH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human Cancer cells</article-title><source>Biomedicine &amp; Pharmacotherapy</source><volume>67</volume><fpage>305</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2013.01.004</pub-id><pub-id pub-id-type="pmid">23582784</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname> <given-names>SL</given-names></name><name><surname>Cappell</surname> <given-names>SD</given-names></name><name><surname>Tsai</surname> <given-names>FC</given-names></name><name><surname>Overton</surname> <given-names>KW</given-names></name><name><surname>Wang</surname> <given-names>CL</given-names></name><name><surname>Meyer</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at Mitotic exit</article-title><source>Cell</source><volume>155</volume><fpage>369</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.08.062</pub-id><pub-id pub-id-type="pmid">24075009</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stifter</surname> <given-names>SA</given-names></name><name><surname>Bhattacharyya</surname> <given-names>N</given-names></name><name><surname>Sawyer</surname> <given-names>AJ</given-names></name><name><surname>Cootes</surname> <given-names>TA</given-names></name><name><surname>Stambas</surname> <given-names>J</given-names></name><name><surname>Doyle</surname> <given-names>SE</given-names></name><name><surname>Feigenbaum</surname> <given-names>L</given-names></name><name><surname>Paul</surname> <given-names>WE</given-names></name><name><surname>Britton</surname> <given-names>WJ</given-names></name><name><surname>Sher</surname> <given-names>A</given-names></name><name><surname>Feng</surname> <given-names>CG</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Visualizing the selectivity and dynamics of interferon signaling in Vivo</article-title><source>Cell Reports</source><volume>29</volume><fpage>3539</fpage><lpage>3550</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.11.021</pub-id><pub-id pub-id-type="pmid">31825834</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Süel</surname> <given-names>GM</given-names></name><name><surname>Garcia-Ojalvo</surname> <given-names>J</given-names></name><name><surname>Liberman</surname> <given-names>LM</given-names></name><name><surname>Elowitz</surname> <given-names>MB</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>An excitable gene regulatory circuit induces transient cellular differentiation</article-title><source>Nature</source><volume>440</volume><fpage>545</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1038/nature04588</pub-id><pub-id pub-id-type="pmid">16554821</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamiya</surname> <given-names>T</given-names></name><name><surname>Kashiwagi</surname> <given-names>I</given-names></name><name><surname>Takahashi</surname> <given-names>R</given-names></name><name><surname>Yasukawa</surname> <given-names>H</given-names></name><name><surname>Yoshimura</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>31</volume><fpage>980</fpage><lpage>985</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.110.207464</pub-id><pub-id pub-id-type="pmid">21508344</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname> <given-names>Y</given-names></name><name><surname>Zhou</surname> <given-names>G</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Chen</surname> <given-names>W</given-names></name><name><surname>Gao</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>USP18 promotes breast Cancer growth by upregulating EGFR and activating the AKT/Skp2 pathway</article-title><source>International Journal of Oncology</source><volume>53</volume><fpage>371</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.3892/ijo.2018.4387</pub-id><pub-id pub-id-type="pmid">29749454</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarhini</surname> <given-names>AA</given-names></name><name><surname>Gogas</surname> <given-names>H</given-names></name><name><surname>Kirkwood</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>IFN-α in the treatment of melanoma</article-title><source>The Journal of Immunology</source><volume>189</volume><fpage>3789</fpage><lpage>3793</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1290060</pub-id><pub-id pub-id-type="pmid">23042723</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tay</surname> <given-names>S</given-names></name><name><surname>Hughey</surname> <given-names>JJ</given-names></name><name><surname>Lee</surname> <given-names>TK</given-names></name><name><surname>Lipniacki</surname> <given-names>T</given-names></name><name><surname>Quake</surname> <given-names>SR</given-names></name><name><surname>Covert</surname> <given-names>MW</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Single-cell NF-kappaB dynamics reveal digital activation and analogue information processing</article-title><source>Nature</source><volume>466</volume><fpage>267</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1038/nature09145</pub-id><pub-id pub-id-type="pmid">20581820</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thurley</surname> <given-names>K</given-names></name><name><surname>Wu</surname> <given-names>LF</given-names></name><name><surname>Altschuler</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Modeling Cell-to-Cell communication networks using Response-Time distributions</article-title><source>Cell Systems</source><volume>6</volume><fpage>355</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2018.01.016</pub-id><pub-id pub-id-type="pmid">29525203</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toettcher</surname> <given-names>JE</given-names></name><name><surname>Weiner</surname> <given-names>OD</given-names></name><name><surname>Lim</surname> <given-names>WA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Using optogenetics to interrogate the dynamic control of signal transmission by the ras/Erk module</article-title><source>Cell</source><volume>155</volume><fpage>1422</fpage><lpage>1434</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.11.004</pub-id><pub-id pub-id-type="pmid">24315106</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuno</surname> <given-names>T</given-names></name><name><surname>Mejido</surname> <given-names>J</given-names></name><name><surname>Zhao</surname> <given-names>T</given-names></name><name><surname>Schmeisser</surname> <given-names>H</given-names></name><name><surname>Morrow</surname> <given-names>A</given-names></name><name><surname>Zoon</surname> <given-names>KC</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha</article-title><source>Journal of Immunotherapy</source><volume>32</volume><fpage>803</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1097/CJI.0b013e3181ad4092</pub-id><pub-id pub-id-type="pmid">19752753</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname> <given-names>T</given-names></name><name><surname>Sugauchi</surname> <given-names>F</given-names></name><name><surname>Tanaka</surname> <given-names>Y</given-names></name><name><surname>Matsuura</surname> <given-names>K</given-names></name><name><surname>Yatsuhashi</surname> <given-names>H</given-names></name><name><surname>Murakami</surname> <given-names>S</given-names></name><name><surname>Iijima</surname> <given-names>S</given-names></name><name><surname>Iio</surname> <given-names>E</given-names></name><name><surname>Sugiyama</surname> <given-names>M</given-names></name><name><surname>Shimada</surname> <given-names>T</given-names></name><name><surname>Kakuni</surname> <given-names>M</given-names></name><name><surname>Kohara</surname> <given-names>M</given-names></name><name><surname>Mizokami</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of the <italic>IL28B</italic> gene</article-title><source>Gut</source><volume>62</volume><fpage>1340</fpage><lpage>1346</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2012-302553</pub-id><pub-id pub-id-type="pmid">23135762</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodcock</surname> <given-names>DM</given-names></name><name><surname>Simmons</surname> <given-names>DL</given-names></name><name><surname>Crowther</surname> <given-names>PJ</given-names></name><name><surname>Cooper</surname> <given-names>IA</given-names></name><name><surname>Trainor</surname> <given-names>KJ</given-names></name><name><surname>Morley</surname> <given-names>AA</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Delayed DNA methylation is an integral feature of DNA replication in mammalian cells</article-title><source>Experimental Cell Research</source><volume>166</volume><fpage>103</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/0014-4827(86)90511-2</pub-id><pub-id pub-id-type="pmid">2427346</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>HW</given-names></name><name><surname>Chung</surname> <given-names>M</given-names></name><name><surname>Kudo</surname> <given-names>T</given-names></name><name><surname>Meyer</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Competing memories of mitogen and p53 signalling control cell-cycle entry</article-title><source>Nature</source><volume>549</volume><fpage>404</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1038/nature23880</pub-id><pub-id pub-id-type="pmid">28869970</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname> <given-names>W</given-names></name><name><surname>Kim</surname> <given-names>JH</given-names></name><name><surname>Handidu</surname> <given-names>A</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Kim</surname> <given-names>KI</given-names></name><name><surname>Yan</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Microarray analysis reveals that type I interferon strongly increases the expression of immune-response related genes in Ubp43 (Usp18) deficient macrophages</article-title><source>Biochemical and Biophysical Research Communications</source><volume>356</volume><fpage>193</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2007.02.101</pub-id><pub-id pub-id-type="pmid">17349616</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.58825.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Graw</surname><given-names>Frederik</given-names></name><role>Reviewing Editor</role><aff><institution>Heidelberg University</institution><country>Germany</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>In this paper, the authors used a combination of experimental analyses and mathematical modeling to discover opposing effects of IFN (priming vs desensitization) in one cellular system. The results suggest that a delayed up-regulation of a negative feedback protein (<italic>USP18</italic>) can explain the opposite functional effect of varying input durations of IFN. By studying heterogeneous behaviors of single cells, the authors revealed a cell cycle-dependent, promoter methylation-mediated mechanism underlying the expression of this protein. Discovery of these IFN opposing effects in one system is novel, and reconciling the paradox by different kinetics of positive and negative feedback loops is fundamentally important for understanding complex IFN signaling. This study shows how a combination of detailed experimental analyses and mathematical modeling can reveal fundamental insights on individual cellular signaling dynamics.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Cell cycle-gated feedback control mediates desensitization to interferon stimulation&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Aleksandra Walczak as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>As the editors have judged that your manuscript is of interest, but as described below that additional analyses are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is &quot;in revision at <italic>eLife</italic>&quot;. Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)</p><p>Summary:</p><p>In this paper “Cell cycle-gated feedback control mediates desensitization to interferon stimulation”, the authors used endogenous labeling and time-lapse microscopy, and discovered that IFN leads to opposing effects (priming vs desensitization), depending on durations of its pretreatment. Modeling and experimental results suggest a delayed up-regulation of negative feedback protein <italic>USP18</italic> can explain the opposite function of different input duration. Further, the authors studied heterogeneous behaviors of single cells and revealed a cell cycle-dependent, promoter methylation-mediated mechanism underlying the expression of <italic>USP18</italic>.</p><p>Overall, this is an interesting study and the authors investigate a timely and relevant question. Discovery of IFN opposing effects in one system is novel, and reconciling the paradox by different kinetics of positive and negative feedback loops is fundamentally important for understanding complex IFN signaling. The manuscript is well written and the work is clearly presented. However, a more detailed and thorough analysis and discussion of the presented data and the used mathematical model is suggested to support the proposed mechanisms. In particular this applies to the following points:</p><p>a) The key conclusions of the manuscript indicating the influence of cell cycle phases on regulation of <italic>USP18</italic> expression and heterogeneity should be corroborated by additional analyses and discussion of alternative hypotheses.</p><p>b) The statistical analyses and representation, especially for the single-cell data, has to be improved.</p><p>c) The analyses of the mathematical model could be improved by making an effort for more quantitative comparisons to data, indicating uncertainty in parameter estimates and by relating it to previous analytical work.</p><p>These aspects will be subject to re-review to determine if these issues have been satisfactorily addressed. We would like to point you to the specific points raised below that contain some suggestions of how to improve the analyses.</p><p>Essential revisions:</p><p>1) A key conclusion of this manuscript is that cell cycle phases regulate <italic>USP18</italic> expression. Figure 5A is the essential and sole evidence to support this causality: G1/S arrest by synchronization results in earlier <italic>USP18</italic> up-regulation, and thus shorter delay time. However, without showing the distribution of activation time for <italic>USP18</italic> and IRF9, it is not clear whether this is the case. An alternative explanation of the shorter delay time would be delayed IRF9 expression by synchronization. Or, some combination of the two possibilities. Re-analysis of the imaging data may be able to address this.</p><p>2) The authors proposed that differential cell cycle phases is the reason for cell-to-cell variation of <italic>USP18</italic> expression. However, Figure 5C suggests cell cycle only partially correlates with <italic>USP18</italic> expression (~half G2 cells have the same activation time as G1/S cells). Alternatively, or in addition, expression/activity of the positive regulator ISGF3 may contribute to the heterogeneous <italic>USP18</italic> expression. Indeed, Figure 4—figure supplement 1 shows variations of nuclear/cyto STAT1 ratio at single cell level. The degree to which pre-existing heterogeneity in ISGF3 contributes to the observed heterogeneity in <italic>USP18</italic> expression should be tested. A reasonable step could be to reanalyze the relationship of <italic>USP18</italic> expression with STAT1 expression/activation or IRF9 expression.</p><p>3) A differential regulation of the positive regulator IRF9 and negative regulator <italic>USP18</italic> by promoter methylation was proposed. Direct evidence is necessary to support this claim, e.g. show the distributions of both IRF9 and <italic>USP18</italic> activation time in control and decitabine.</p><p>4) Kinetic model (Figure 3): to keep the model simple, the authors considered only protein production but not decay. However, based on this assumption, it would seem that repetitive IFN pulses (Figure 3D) should lead to IRF9 accumulation after each round of pulse and ultimately activation of <italic>USP18</italic>, just as in the sustained pretreatment case. The authors need to support this critical modeling assumption.</p><p>5) In the adjusted model (Figure 6), the authors assume that the IFN input onset time is uniformly distributed within a cell cycle. However, this is inconsistent with the fact that HeLa cells spend the longest time in G1, moderate time in S, and progress fast through G2/M.</p><p>6) The authors collected an impressive amount of kinetic single-cell data, giving new insight into the cellular mechanisms of the interferon response. Unfortunately, that data is in large parts simply plotted, and not analyzed systematically. Therefore, it is not always clear how to interpret the extra information from single-cell data. In many cases only the average is taken from several independent single-cell experiments (e.g. Figure 1F, Figure 3F). In other cases, properties such as &quot;bimodality&quot; (Figure 4D) or &quot;different kinetics&quot; (Figure 4C) are just stated heuristically without any quantitative analysis. Even though a stochastic mathematical model is included (Figure 6), no effort is made to quantitatively compare model results and single-cell data. In Figure 6C, stochastic simulations of the model are able to qualitatively reproduce the observed experimental data. Although measured in arbitrary units, the quantitative measurements for the IRF9 induction seem to be smaller than in the experimental data (~roughly only half the average values) especially for short periods of IFN-pretreatment, with the 2h-simulations also not matching the trend observed in the experimental data between the different conditions. How sensitive are these predictions dependent on the parameter choices for the model? Given the complexity of the model and the type of data used for fitting, parameter identifiability might be impaired.</p><p>7) At various instances, the manuscript falls short on statistical analysis. It is not always clear how error bars are calculated, and whether or not all shown single-cell data points stem from the same experiment or the same set of experiments. Further, image quantification and statistical tests are almost entirely missing.</p><p>8) The presented mathematical model is a valuable addition to the paper, with the potential to both rationalize and quantify the experimental results. However, it should be pointed out that the structure of the model follows a well-studied topology, namely the &quot;persistence detector&quot; motif (Shen-Orr et al., 2002; Mangan et al., 2003), which was more recently also studied in kinetic single-cell experiments (Toettcher, Weiner and Lim, 2013) and in a data-driven model of cell-cell communication (Thurley, Wu and Altschuler, 2018). Therefore, it is not surprising that the model captures an improved response to a pulsed input as compared to a sustained input, as shown in Figure 3. In the presented model, the original feed-forward loop is replaced by direct delay (as in some other implementations such as Thurley et al.), and is supplemented by additional, coupled positive and negative feedback loops. It remains unclear to what extent that loop is required for the observed effect, since analysis remains limited to variation of the delay time (Figure 3B). More specifically – would the simple delay mechanism alone, without any feedback, be sufficient to explain the data in Figure 3C? And how much do the individual feedbacks contribute to the final results?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.58825.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) A key conclusion of this manuscript is that cell cycle phases regulate USP18 expression. Figure 5A is the essential and sole evidence to support this causality: G1/S arrest by synchronization results in earlier USP18 up-regulation, and thus shorter delay time. However, without showing the distribution of activation time for USP18 and IRF9, it is not clear whether this is the case. An alternative explanation of the shorter delay time would be delayed IRF9 expression by synchronization. Or, some combination of the two possibilities. Re-analysis of the imaging data may be able to address this.</p></disp-quote><p>We thank the reviewers for this insightful suggestion. We have now provided the distributions of activation times for both <italic>IRF9</italic> and <italic>USP18</italic> in new Figure 5—figure supplement 1. As shown in the figure, G1/S arrest leads to earlier <italic>USP18</italic> upregulation in cells treated with serum starvation, lovastatin, and roscovitine. In contrast, <italic>IRF9</italic> activation times were affected very modestly by either serum starvation or lovastatin. Roscovitine results in a slight delay in <italic>IRF9</italic> upregulation but a dramatic acceleration in <italic>USP18</italic> upregulation. Therefore, the shorter delay times in Figure 5A were mainly due to earlier <italic>USP18</italic> upregulation upon G1/S arrest. We have also included, in the figure legend, the mean, the 95% confidence interval, and coefficient of variance (CV) for each distribution to demonstrate these changes quantitatively. We have added text to describe these results and clarify this point in subsection “Cell cycle phases differentially regulate <italic>USP18</italic> expression”.</p><disp-quote content-type="editor-comment"><p>2) The authors proposed that differential cell cycle phases is the reason for cell-to-cell variation of USP18 expression. However, Figure 5C suggests cell cycle only partially correlates with USP18 expression (~half G2 cells have the same activation time as G1/S cells). Alternatively, or in addition, expression/activity of the positive regulator ISGF3 may contribute to the heterogeneous USP18 expression. Indeed, Figure 4—figure supplement 1 shows variations of nuclear/cyto STAT1 ratio at single cell level. The degree to which pre-existing heterogeneity in ISGF3 contributes to the observed heterogeneity in USP18 expression should be tested. A reasonable step could be to reanalyze the relationship of USP18 expression with STAT1 expression/activation or IRF9 expression.</p></disp-quote><p>We appreciate this thoughtful suggestion. As requested, we have analyzed the relationship of <italic>USP18</italic> expression with that of <italic>IRF9</italic> or STAT1 at the single-cell level and showed the scatter plots and correlation coefficients in new Figure 4—figure supplement 2. We observed that the heterogeneity in these upstream components contributes partially to cell-to-cell variation in the expression levels of USP18. However, the delay times of <italic>USP18</italic> upregulation correlate poorly with STAT1 or IRF9 expression. We have added text to describe and discuss these results in subsection “The kinetics of <italic>USP18</italic> upregulation by IFN is heterogeneous in single cells”.</p><disp-quote content-type="editor-comment"><p>3) A differential regulation of the positive regulator IRF9 and negative regulator USP18 by promoter methylation was proposed. Direct evidence is necessary to support this claim, e.g. show the distributions of both IRF9 and USP18 activation time in control and decitabine.</p></disp-quote><p>We thank the reviewers for this request. We have now provided the distributions of activation times for both <italic>IRF9</italic> and <italic>USP18</italic> in control and decitabine in new Figure 5—figure supplement 4. As shown in the figure, the decitabine treatment shortened the activation times for <italic>USP18</italic>, while modestly affecting <italic>IRF9</italic> expression. We have also included, in the figure legend, the mean, the 95% confidence interval, and coefficient of variance (CV) for each distribution to demonstrate these changes quantitatively. We have added text to describe these results in subsection “Cell cycle phases differentially regulate <italic>USP18</italic> expression”.</p><disp-quote content-type="editor-comment"><p>4) Kinetic model (Figure 3): to keep the model simple, the authors considered only protein production but not decay. However, based on this assumption, it would seem that repetitive IFN pulses (Figure 3D) should lead to IRF9 accumulation after each round of pulse and ultimately activation of USP18, just as in the sustained pretreatment case. The authors need to support this critical modeling assumption.</p></disp-quote><p>We thank the review for this suggestion. During the time scales of our experiments, we observed very modest decays of STAT1, IRF9 and USP18. We clarified this in Materials and methods subsection “Computational modeling”. In the model (Figure 3E), the short pulsatile input is less able to induce USP18 upregulation than the sustained input, because the expression delay of USP18 filters out the short inputs. This weaker induction of the negative regulator USP18 accounts for the higher IRF9 induction by the pulsatile input. We have modified the text in subsection “Computational modeling suggests a delayed negative feedback loop through <italic>USP18</italic>” to clarify this point.</p><disp-quote content-type="editor-comment"><p>5) In the adjusted model (Figure 6), the authors assume that the IFN input onset time is uniformly distributed within a cell cycle. However, this is inconsistent with the fact that HeLa cells spend the longest time in G1, moderate time in S, and progress fast through G2/M.</p></disp-quote><p>We apologize for the unclarity of our model description. In our simulations, we assumed that the IFN onset time for each single cell is a random time point uniformly distributed within a cell cycle. However, in our model, the periods of different cell cycle phases, e.g. G1, S and G2/M, are not equally distributed within a cell cycle, and hence the probabilities of the IFN input onset time falling at different cell cycle phases are not equal. We have revised the text in subsection “Cell cycle-gated feedback control shapes single-cell responses to repetitive IFN inputs” to clarify this assumption.</p><disp-quote content-type="editor-comment"><p>6) The authors collected an impressive amount of kinetic single-cell data, giving new insight into the cellular mechanisms of the interferon response. Unfortunately, that data is in large parts simply plotted, and not analyzed systematically. Therefore, it is not always clear how to interpret the extra information from single-cell data. In many cases only the average is taken from several independent single-cell experiments (e.g. Figure 1F, Figure 3F). In other cases, properties such as &quot;bimodality&quot; (Figure 4D) or &quot;different kinetics&quot; (Figure 4C) are just stated heuristically without any quantitative analysis.</p></disp-quote><p>We thank the reviewer for the positive comments. As for the request of additional analysis and quantification, we have now performed quantification and statistical analysis for the data in Figure 1F, Figure 2, Figure 4, Figure 5 and their figure supplements.</p><disp-quote content-type="editor-comment"><p>Even though a stochastic mathematical model is included (Figure 6), no effort is made to quantitatively compare model results and single-cell data. In Figure 6C, stochastic simulations of the model are able to qualitatively reproduce the observed experimental data. Although measured in arbitrary units, the quantitative measurements for the IRF9 induction seem to be smaller than in the experimental data (~roughly only half the average values) especially for short periods of IFN-pretreatment, with the 2h-simulations also not matching the trend observed in the experimental data between the different conditions. How sensitive are these predictions dependent on the parameter choices for the model? Given the complexity of the model and the type of data used for fitting, parameter identifiability might be impaired.</p></disp-quote><p>We thank the reviewer for the request of additional analyses of modeling results. We have now performed parameter sensitivity analysis and the quantitative comparison between model results and the data. We also added discussions about the limitations of the model.</p><disp-quote content-type="editor-comment"><p>7) At various instances, the manuscript falls short on statistical analysis. It is not always clear how error bars are calculated, and whether or not all shown single-cell data points stem from the same experiment or the same set of experiments. Further, image quantification and statistical tests are almost entirely missing.</p></disp-quote><p>We apologize for the unclarity of data presentation and the lack of statistical analysis and quantification. We have now added the missing information, quantification, and statistical tests.</p><disp-quote content-type="editor-comment"><p>8) The presented mathematical model is a valuable addition to the paper, with the potential to both rationalize and quantify the experimental results. However, it should be pointed out that the structure of the model follows a well-studied topology, namely the &quot;persistence detector&quot; motif (Shen-Orr SS et al., 2002; Mangan et al., 2003), which was more recently also studied in kinetic single-cell experiments (Toettcher, Weiner and Lim, 2013) and in a data-driven model of cell-cell communication (Thurley, Wu and Altschuler, 2018). Therefore, it is not surprising that the model captures an improved response to a pulsed input as compared to a sustained input, as shown in Figure 3. In the presented model, the original feed-forward loop is replaced by direct delay (as in some other implementations such as Thurley et al.), and is supplemented by additional, coupled positive and negative feedback loops. It remains unclear to what extent that loop is required for the observed effect, since analysis remains limited to variation of the delay time (Figure 3B). More specifically – would the simple delay mechanism alone, without any feedback, be sufficient to explain the data in Figure 3C? And how much do the individual feedbacks contribute to the final results?</p></disp-quote><p>We thank the reviewer for this insightful comment and for pointing us to relevant previous studies. We have now added text in paragraph two of the Discussion to further our discussion about network motifs and gene expression delay and cited these relevant papers.</p><p>In addition, we performed sensitivity analysis for all the parameters in the model. As shown in new Figure 3—figure supplement 1C, both positive and negative feedback loops (governed by k<sub>1</sub>, k<sub>2</sub> and k<sub>3</sub>) are important for the observed effects in Figure 3C. For example, if the strength of positive feedback loop is too weak (k<sub>1</sub> is too small), the priming effect by 10-hr pretreatment will be abolished. Similarly, if the activation threshold for the negative feedback is too high (k<sub>3</sub> is too large), the desensitization effect by 24-hr pretreatment will be abolished. We have added text in subsection “Computational modeling suggests a delayed negative feedback loop through <italic>USP18</italic>” to describe these results.</p></body></sub-article></article>